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ABSTRACT 
Acinetohacter species are important nosocomial pathogens in Hong Kong. In this 
project, the prevalence of Acinetohacter in clinical specimens and the distribution 
of different Acinetohacter genomic species in clinical, carriage sites and 
environmental sources were studied. 
A total of 52 isolates of Acinetohacter spp. from surveillance screening of clinical 
samples, 134 isolates reported by the routine laboratory, Prince of Wales Hospital, 
Hong Kong, 235 from human carriage sites, 45 from vegetables and 34 from soil 
were collected. The isolates were classified by Amplified Ribosomal DNA 
Restriction Analysis (ARDRA). The prevalence of Acinetohacter spp. in clinical 
specimens was 2.4%, with the lower respiratory tract accounting for the highest 
number of isolates (11%). Of these, A. baumannii and genomic DNA group 3 were 
the common species, accounting for 31% and 29%, respectively. In the blood 
culture isolates of 1997 to 1998, genomic DNA group 3 was the commonest species, 
accounting for 40% of all acinetobacters isolates. Genomic DNA group 3 was also 
the commonest species in human carriage sites and environmental samples, such as 
vegetables and soil in this project. 
i 
The in vitro susceptibility of different Acinetobacter genomic DNA groups against 
11 antimicrobial agents was studied. A. haumannii was the most resistant species. 
We also showed that isolates of genomic DNA group 3 from clinical sources were 
more resistant than those from carriage sites or environment. 
All together, 136 acinetobacters were selected to assess the usefulness of tDNA 
fingerprinting for the identification of Acinetobacter species. The results showed 
that tDNA fingerprinting was not able to delineate unambiguously all 
Acinetobacter species. It grouped isolates of Acb complex together and therefore 











於泥土樣本，這些不動桿菌株都嘗試使用Amplified Ribosomal DNA restriction 
Analysis (ARDRA)種類分類方法所分類。我們從臨床樣本的調查硏究發現， 
不動桿菌於臨床樣本的普遍性爲2.4%，其中已下呼吸道的樣本爲多數，佔全 
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Definitions are given below the most common terms used in this thesis. 
AUA: If strains or isolates are found to have an ARDRA profile unmatched with 
the existing ARDRA profiles database as shown in Appendix I, then they are called 
"ARDRA unclassifiable acinetobacters" 
Genomic DNA groups (GDG): The division of genomic DNA groups of 
Acinetobacter isolates should be based on DNA-DNA relatedness and those cannot 
be differentiated phenotypically should not be named. 
Genus: A collection of species with many characters in common. The taxonomic 
rank between species and family. 
Isolate: Isolate is a general term for a pure culture of bacteria obtained by 
subculture of a single colony from a primary isolation plate, presumed to be derived 
from a single organism, for which no information is available aside from its genus 
and species. 
xiii 
Outbreak: An outbreak is the increased incidence of an infectious disease in a 
specific place during a given period that is above the baseline rate for that place and 
time frame. 
Species: A taxonomic group below the genus level in the taxonomic hierarchy, 
which is based on approximately 70% or greater DNA-DNA relatedness of strains 
and phenotypic characteristics should agree with this species classification. 
Strain: A strain is an isolate or group of isolates that can be distinguished from 
other isolates of the same genus and species by phenotypic characteristics or 
genotypic characteristics or both. A strain is a descriptive subdivision of a species. 
Taxonomy: The science of classification. 
xiv 
CHAPTER 1 INTRODUCTION 
1.1 History and taxonomic background of Acinetohacter 
Historical features 
The genus Acinetohacter has a long history of taxonomic change. The first 
recognizable member of this group was a soil organism isolated by Beijerinck in 
1911, and named by him as Micrococcus calcoaceticus (Baumann 1968). Since 
then, at least 15 other "generic" names have been used to describe the organisms 
now classified as members of the genus, of which the most common were 
Bacterium anitratum, Herellea vaginicola, Mima polymorpha, Alcaligenes, 
"B5W", Moraxella glucidolytica and Moraxella Iwoffii (Henriksen 1973). 
The original concept of the genus Acinetohacter was proposed by a working 
group in France (Brisou 1954). It included a heterogenous collection of non-
motile, gram-negative, oxidase-positive and oxidase-negative saprophytes that 
could be distinguished from other bacteria by their lack of pigmentation. The 
nutritional studies of Baumann, DoudorofF and Stanier (1968) showed that the 
oxidase-negative strains differed from the oxidase-positive strains of the genus 
Moraxella. In 1971 the Subcommittee on the Taxonomy of Moraxella and Allied 
Bacteria recommended that the genus Acinetohacter should include only the 
oxidase-negative strains (Lessel 1971). This division has been supported by the 
use of transformation test (Juni 1972), which forms the basis for inclusion of 
individual isolates into the genus. 
1 
Classification 
Recent taxonomic developments have resulted in the current proposal that 
members of the genus Acinetohacter should be classified in the family 
Moraxellaceae which includes Moraxella, Acinetohacter, Psychrohacter and 
related organisms, and which constitutes a discrete phylometric branch in 
superfamily II of the Proteobacteria on the basis of 16S rRNA studies and 
rRNA:DNA hybridization assays (van Landschoot 1986，Rossau 1989). 
Genus definition 
The genus Acinetohacter is defined as short, Gram-negative coccobacilli, with a 
DNA G+C content of 39-47 mol%. They are strictly aerobic, non-motile, catalase-
positive and oxidase-negative, frequently capsulated (Towner 1997). Good growth 
occurs on common laboratory media, such as nutrient agar, trypticase soya agar, 
between 20 and 37°C without growth factor requirements. Most strains of 
Acinetohacter can grow in a simple mineral medium containing ammonium salts 
and a single carbon as energy source such as acetate, lactate or pyruvate, but only 
rarely with glucose. Some strains form acid from sugars, but many do not. 
Nitrates are reduced only rarely (Towner 1997). Crucially, extracted DNA is able 
to transform mutant Acinetohacter strain BD413 tryEll to the wild-type 
phenotype (Juni 1972). 
Delineation of species 
A formal molecular definition of a species has been proposed in 1987 (Wayne 
1987). It states that a species should include strains with approximately 70% or 
greater DNA-DNA relatedness and 5°C or less divergence values (ATm). 
2 
Extensive studies of DNA-DNA relationships within the genus of Acinetobacter 
have resulted in the recognition, to date, of 19 genomic DNA groups. There are 
some minor discrepancies in the numbering schemes proposed for genomic DNA 
groups by different laboratories, but 7 of the genomic DNA groups have been 
given formal species names which form the basis of current taxonomy (Table 1.1). 
A definitive numbering scheme has yet to be finally agreed. Indeed, groups 1, 2, 
3, of Bouvet and Grimont (1986) and 13 of Tjernberg and Ursing (1989) have 
been shown to have an extremely close relationships and are referred to by most 
research groups as “A. calcoaceticus-A. baumannii complex" or Acb complex. 
Table 1.1 Delineation of Acinetobacter genomic DNA groups 
Genomic DNA groups number according to 
Species name Bouvet and Grimont (1986) Tjernberg and Ursing (1989) 
Bouvet and Jeanjean (1989) 
A. calcoaceticus 1 1 
A. baumannii 2 2 
3 3 
Ungrouped 13TU 
A. haemolyticus 4 4 
A. junii 5 5 
6 6 
A. johnsonii 7 7 




A. radioresistens 12 12 
13BJ 14TU 
14BJ Not tested 
15BJ Not tested 
16 Ungrouped 
17 Not tested  
Not tested 15TU  
3 
1.2 Microbiology, ecology and habitats oi Acinetobacter species 
1.2.1 Isolation of Acinetobacter 
The culture medium for isolation of acinetobacters used was different in various 
studies. Allen and Green (1987) inoculated the specimens on MacConkey agar 
plates containing 10}ig/ml gentamicin, but Weernink (1995) used blood agar 
plates containing 16|Lig/ml cefazolin. Neither medium was suitable for the 
isolation of antibiotic-susceptible strains such as A. Iwoffi or A. johnsonii. A 
selective medium comprising sugars, bile salts and bromocresol purple, available 
commercially as Herellea Agar (Difco), was described by Mandel et al (1964). 
The medium was later modified to Holton agar containing vancomycin, 
ampicillin, cefsulodin, sugars and phenylalanine. Recently, another selective 
medium, the Leeds Acinetobacter Medium (LAM) was described to be suitable 
for the recovery of Acinetobacter spp. from clinical and environmental samples 
(Jawad 1994). In order to meet the requirements of all acinetobacters especially 
for the isolates from non-clinical origin, an incubation temperature of 30°C has 
been recommended (Hugh 1978). 
Selection of acinetobacters can also be achieved by enrichment cultivation. 
Baumann (1968) developed an enrichment culture medium for isolation of 
acinetobacters from soil and water. It involved the use of mineral media at low pH 
(5.5-6.0), supplemented with acetate as a single carbon source and nitrate as 
nitrogen source. Vigorous shaking during incubation is needed in order to outgrow 
pseudomonads. After 24 to 48 hrs incubation at 30°C, a loopful of the culture was 
inoculated onto solid media. Enrichment cultivation by using acetate has been 
used for recovery of acinetobacters from specimens from patients and their 
environments (Grehn 1978, Dijkshoom 1987). 
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1.2.2 Clinical importance of Acinetobacter spccics 
Acinetobacters have been isolated from various types of opportunistic infections, 
including septicaemia, pneumonia, endocarditis, meningitis, infections of the skin, 
wounds and the urinary tract (French 1980, Ng 1989, Joly-Guillou 1992). 
Acinetobacter is associated predominantly with nosocomial infections, but some 
cases of community-acquired infections have been reported (Rudin 1979， 
Hoffinann 1982). Although Acinetobacter is an opportunistic organism of 
relatively low virulence, severe infections do occur, especially in 
immunocompromised patients or patients after invasive diagnostic or therapeutic 
procedures. 
Acinetobacter has emerged as a particularly important nosocomial pathogen in 
intensive care units (ICDs). Acinetobacter causes clinically significant respiratory, 
neonatal and burns infections (Gemer-Sniidt 1987, Ng 1993, Sheretz 1985). 
Various predisposing factors have been identified over the years, including major 
surgery, a stay in ICUs, assisted ventilation, recent antimicrobial therapy, bums 
and malignant diseases. 
For many years it has been difficult to assess the clinical significance of 
Acinetobacter infection as the taxonomy of the genus has been changed on several 
occasions. In early decades, species identification was problematic. For example, 
Allen (1987) and Gemer-Smidt (1987) reported hospital outbreaks of infections 
caused by A. anitratus and A. calcoaceticus biovar anitratus, respectively. Were 
they referring to the same species? In the paper by Allen et al (1987), the bacteria 
were identified by the API 20NE system (BioMerieux, France), but in Gerner-
Smidt's (1987) work the identification was based on the Hugh's study (1978), i.e. 
Gram-negative coccobacillus, strictly aerobic, non-motile, non-spore forming, 
5 
oxidase-negative, nitrate negative growing on modified Conradi-Drigalski agar. 
The same problem has also been observed in later publications. Identification of 
acinetobacters is often based on the database of commercial kits, such as API 
20NE (BioMerieux, France) or Vitek - GNI (BioMerieux, France) system. 
However, these systems include only some of the genomic DNA groups. For 
example, API20 NE (version 6.0) includes only the seven named species. 
Based on the recent taxonomic criteria, numerous studies have showed that A. 
baumannii is the main genomic DNA group associated with outbreaks of 
nosocomial infection (Bouvet 1987). However, very little is known about the 
clinical significance of Acinetohacter species other than A. baumannii. 
Acinetohacter genomic DNA group 3 has been reported in Sweden, to cause an 
outbreak of infection in a neonatal ICU (Dijkshoorn 1993). A. johnsonii was 
described to be associated with catheter related bacteraemia (Seifert 1993). 
1.2.3 Acinetohacter - An endemic nosocomial pathogen of particular 
importance in Hong Kong 
Infection with Acinetohacter species is of particular importance in Hong Kong, 
with a prevalence of infection higher than elsewhere, e.g. isolation rates of 
Acinetohacter in blood cultures ranged from 0.24% to 0.68% from 1987 to 1994 
(Ng 1996, Siau 1996). In Hong Kong, there has been a substantial increase in the 
incidence of Acinetohacter bacteraemia. The incidence of bacteraemia doubled 
between 1987 and 1994, with an isolation rate from 0.24% to 0.68% (Ling 1996). 
A retrospective study of clinical characteristics of Acinetohacter bacteraemia was 
conducted in 1993-1994 (Ng 1996), the authors reported that 70 of 94 
Acinetohacter bacteraemic episodes in 67 patients were of clinical significance. 
6 
The ICU was the commonest location of acquisition of bacteraemia and most 
infections were hospital-acquired. They reported that Acinetobacter bacteraemia 
was associated with a mortality rate of 27%. 
Besides, acinetobacters were frequently resistant to multiple antimicrobial agents 
including most of the p-lactams and aminoglycosides. Ling et al. (1996) reported 
the rate of resistance of Acinetobacter isolates from blood culture from 1990 to 
1994 were high, being 30% resistant to gentamicin, 13% to ciprofloxacin and 92% 
to cefotaxime. Only amikacin, imipenem and meropenem were reliably active 
against acinetobacters. 
1.2.4 Lack of knowledge of Acinetobacter genomic DNA groups 
The taxonomic confusion and technical difficulties of phenotypic identification 
methods have thrown doubt on the scanty data published on the genus ecology 
and epidemiology. For example, there are problems in distinguishing genomic 
DNA groups most commonly found in clinical specimens from hospital patients, 
e.g. genomic DNA groups 2, 3 and 13TU. Genomic DNA groups 5, 7 and 8/9 
seem to be prevalent in specimens from general practice but their biological 
significance is not clear (Bouvet and Grimont 1987, Tjemberg and Ursing 1989). 
With the recent molecular techniques, e.g. amplified ribosomal DNA restriction 
analysis (ARDRA), we are now in a position to address questions concerning the 
ecology of the genomic DNA groups in terms of clinical significance and 
geographic spread, thereby allowing the pathogenicity of particular strains to be 
elucidated. 
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1.2.5 Human carriage of Acinetohacter species 
Acinetohacter can be readily isolated from different skin sites of hospitalized 
patients or healthy subjects. The isolation rates varied in different studies (Table 
1.2). Some data were based on results of epidemiological surveillance (Struelens 
1993, Wise 1990, Allen 1987，Timsit 1993). Allen et al (1987) reported that the 
human skin carriage rate was 8-35%, but the skin surveillance was carried out 
during a hospital outbreak of Acinetohacter infection. In addition, the isolation of 
acinetobacters was performed by inoculating of swabs onto MacConkey agar 
plates containing lO^ig/ml gentamicin, incubated at 37°C and the identification 
was based on the API 20NE system. Wise et al, (1990) reported that isolation rate 
of acinetobacters from rectal swabs was 15 to 92%. However, they only 
investigated a single medical unit — the spinal cord injuries unit and the isolation 
of acinetobacters was performed on MacConkey agar plates containing 8|j.g/ml of 
gentamicin incubated at YTC and the identification was based on API 2ONE. 
Timsit et al. (1993) also suggested that the digestive tract was an important 
reservoir for Acinetohacter baumannii. They found a high rate of rectal carriage 
(24%) of A. baumannii among 170 patients, but they did not state the culture 
procedures and identification method used (Timsit 1993). 
Recently, there are two studies reported in the literature on skin and mucous 
membrane carriage of Acinetohacter using the DNA classification scheme. Berlau 
et al (1999) described an overall positivity skin carriage rate of 44% in 191 
healthy subjects in London. In Hong Kong, the recently published study on skin 
carriage in Chinese (Chu 1999) showed that 32 to 66% of community volunteers 
and patients were positive at any one of the 5 sampled sites. 
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Table 1.2 Carriage of Acinetohacter by healthy volunteers and hospitalized 
patients in non-outbreak situations 
Sites of carriage Normal subjects (%) Hospitalized patients (%) 
Skin " " 
Antecubital fossae 37^ 
2' 
Axillae lOh 35' 
20® \T 
Toe webs 20 33^ 
Nose - 57a 






a: Allen and Green (1987); b: French (1980); c: Joly-Guillou; d: Rosenthal (1974); e: Rosenthal 
(1975); f: Sakata 1989); g: Somerville (1970); h: Taplin (1963). 
1.2.6 Species from the environment 
Acinetobacters are ubiquitous organisms that can be obtained from soil, water, 
food and sewage (Baumann 1968, Gennari 1993, Gennari 1992, Khan 1992, Khan 
1996). By using the enrichment culture procedure, Baumann (1968) reported that 
Acinetohacter constituted no less than 0.001% of the total heterotrophic aerobic 
population in soil and wastewater and was one of the predominant organisms in 
some water samples. Although the identification of acinetobacters was based on 
their morphological and physiological properties, the development of the 
enrichment culture broth by the use of acetate as single carbon source was 
important for subsequent investigation of distribution of acinetobacters in 
environment as the number of organisms is low (Baumann 1968). 
There have been few studies in which Acinetohacter isolates from environmental 
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sources have been classified according to the latest taxonomic criteria. Gennari et 
al (1993) examined fresh meat (including beef, chicken, turkey, pork, lamb and 
rabbit), raw milk (recovered from milk collecting centers, dairy factories and 
farm), pasteurized milk, butter and cheeses for the presence of acinetobacters. 
Most of the samples were purchased in supermarkets, street markets and other 
retail outlets in Italy. They compared 170 Acinetobacter isolates from various 
environmental sources with 83 isolates from clinical sources. The species 
identification in this study was based on the phenotypic identification scheme of 
Bouvet and Grimont (Bouvet 1986). The results demonstrated a clear difference in 
the distribution of different genomic DNA groups, with A. johnsonii and A. Iwoffii 
predominating in foods. Another recent environmental study was conducted in 
United Kingdom (Berlau 1999). They examined different vegetables purchase 
from supermarkets, greengrocers or harvested from private gardens for the 
presence of acinetobacters which were classified into genomic DNA groups by 
Amplified Ribosomal DNA Restriction Analysis (ARDRA). Although the data 
was comprehensive, both studies were carried out in Europe. There is no 
information on the distribution of different Acinetobacter species in 
environmental samples in other parts of the world. 
1.3 Identification of Acinetobacter 
Genus identification 
The identification of the genus Acinetobacter was based on the following criteria 
(Cowan 1993): Gram-negative coccobacilli, oxidase-negative, non-fermenting in 
0/F test, non-motile in hanging drop preparation, aerobic growth, catalase-
positive, nitrate reduction negative, and hydrolysis of Tween mostly positive. 
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Identification to the genus also includes the test for transformation assay (Juni 
1972). 
Classification of genomic DNA groups 
1.3.1 DNA-DNA hybridization 
Several hybridization methods have been used for the allocation of Acinetohacter 
isolates to genomic DNA groups, including a nitrocellulose filter method 
(Johnson 1970), the SI endonuclease method (Bouvet 1986), the hydroxyapatite 
method (Tjemberg 1989) and a quantitative bacterial dot filter method (Tjernberg 
1989). Overall, these methods are laborious and can only be performed in 
reference laboratories 
1.3.2 Phenotypic identification by conventional tests 
Bouvet and Grimont (1986) described a scheme of 28 phenotypic tests for 
identification of acinetobacters to the genomic DNA groups. This system allows 
differentiation of 11 of 12 genomic DNA groups, leaving only two genomic DNA 
groups (8 and 9) unseparated. Later many researchers modified the scheme or 
introduced other tests into the scheme (Bouvet 1987, Gemer-Smidt 1991, 
Kampfer 1993). Unfortunately, the phenotypic tests cannot be used for the 
unambiguous identification of the genomic DNA groups, in particular for the 
differentiation among the closely related genomic DNA groups 1, 2, 3 and 13TU 
(Acb complex). 
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1.3.3 Geiiotypic identification by Amplified Ribosomal DNA Restriction 
Analysis (ARDRA) 
The amplified ribosomal DNA restriction analysis (ARDRA) is applied to the 
analysis of the 16S rRNA gene. This small subunit rRNA gene (16S rDNA) 
contains highly conserved genes which may function as an evolutionary clock. In 
addition, the gene also contains highly variable sequences that may allow the 
identification of known or previously uncharacteristerized species. In conjunction 
with polymerase chain reaction (PGR), conserved regions of 16S rRNA sequence 
were used as targets for primer-directed DNA amplification, then the amplified 
16S rRNA sequences was subjected to restriction analysis. The method has been 
widely used for identification of Mycobacterium tuberculosis complex, 
Streptococcus spp. and Enterococcus spp. (Vaneechoutte 1993, Jayarao 1992). 
The method itself is flexible for updating the database since it does not require the 
sequence information of newly characterized species but only a pattern of PGR 
fingerprint is needed. Moreover it is a simple method involving a direct one-step 
DNA extraction. The PGR is less subjected to contamination since the DNA 
template is prepared directly from the cultured organism, thus the DNA 
concentration is much higher than DNA from contamination. 
The use of ARDRA for Acinetobacter identification began in 1995 by 
Vaneechoutte et al. (1995). In this pilot study, 53 strains (epidemiologically 
unrelated and mostly of clinical origin), and reference strains belonging to 18 
genomic DNA groups of Acinetobacter were investigated. A universal 16S rRNA 
gene primer was used to amplified the 16S rDNA, the length of the amplified 
DNA is about 1500 bp and then the amplicon was restricted independently with 
different restriction enzymes to obtain the restriction pattern for analysis. 
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Further to the pilot study, the usefulness, both reproducibility and discrimination 
power, of ARDRA method for Acinetobacter species identification was 
intensively tested by Dijkshoom et al (1998). A total of 202 strains, including the 
53 strains from the above study, and reference strains belonging to the 18 genomic 
DNA groups were tested. The results of this study showed that a standard panel of 
enzymes including AM, Cfol, Mbo\, Rsal and Mspl were useful for the 
identification of genomic DNA groups. The additional use of Bfal and Bsmal 
allowed the separation of genomic DNA groups 10 and 11，5 and 17’ and 7 from 4 
and 13BJ/14TU. ARDRA has been used in many studies for the identification of 
Acinetobacter genomic DNA groups (Bernards 1997, Koeleman 1998). It is a 
relatively easy and rapid method. The results are consistent and reproducible. 
1.3.4 Other PGR methods 
Besides ARDRA, other PGR methods have been investigated for the identification 
of Acinetobacter genomic DNA groups. Amplification of the intergenic spacer 
between the 16S and 23 S rRNA genes without restriction analysis was studied 
(Nowak 1995), it was shown to identify only 15 to 17 reference strains tested. 
Another study, using the same PGR method coupled with 2 restriction enzyme 
analyses (ARDRA-spacer) (Dolzani 1995), the usefulness of this method was 
difficult to be assessed because only clinical isolates of Acb complex were used 
and 87% of them belonged to genomic DNA group 2. The usefulness of these 
PCR methods was limited because of the difficulty in the methodology and the 
inability to fiilly differentiate the 19 genomic DNA groups. 
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1.3.5 Genotypic identification by tDNA fingerprinting 
The principle of this technique was based on using a pair of primers of consensus 
tRNA gene to amplify a set of DNA fragments in bacteria. Genomic fingerprints 
are largely conserved within a species and most products in the fingerprints are 
conserved between closely related species. Thus PGR with tRNA gene consensus 
primers can be useful in species identification. Genomic fingerprints produced by 
PGR with tRNA gene primers (tDNA fingerprinting) have been evaluated for 
species identification of Staphylococcus, Streptococcus and Enterococcus (Welsh 
1991). A German research group was the first to evaluate the technique in the 
characterization of Acinetobacter isolates from the wastewater treatment plant 
(Wiedmann 1994). Later a French research group evaluated the tDNA 
fingerprinting identification method against a large panel of isolates identified by 
DNA-DNA hybridization (Ehrenstein 1996). All 31 strains belonging to the Acb 
complex clustered into two distinct tDNA fingerprint pattern types, with one 
cluster containing genomic DNA groups 1 and 3, while the other included 
genomic DNA groups 2 and 13TU. Some genomic DNA groups were 
indistinguishable because only clinical isolates were used in the development of 
the system. 
1.4 Biotyping 
Before the introduction of genotypic typing method, phenotypic typing method, 
such as biotyping, was used for the allocation of strains according to described 
classification schemes. A biotyping scheme comprising five tests was used to 
identify 19 biotypes (Bouvet 1987, Bouvet 1990). This scheme was devised 
initially for typing isolates described as A. baumannii at the time. Later, it has also 
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been used to type the closely related genomic DNA group 3 and 13TU (Bouvet 
1990, Gerner-Smidt 1993). The system allowed the successful biotyping of 
isolates in Bouvet's study (1987). It was sufficiently sensitive to detect the 
existence of two unrelated biotypes causing infection and to distinguish between a 
relapse and new infection by different biotypes (Bouvet 1987, Giammanco 1989). 
However the limitation is that biotyping comprises of only five carbohydrates and 
they are inadequate to discriminate strains and cannot be used as a sole typing 
method. Biotyping system should be used with caution, Gemer-Smidt and 
Tjemberg (1993) showed that the majority of strains identified phenotypically as 
A. baumannii bio type 9 actually belonged to genomic DNA group 13TU. Without 
the identification of isolates to the species level, incorrect epidemiological 
conclusions could be drawn. 
1.5 Background of this research project 
1.5.1 Distribution of different species of Acinetohacter 
Acinetohacter species are widely distributed in nature and have been isolated from 
plants, water, soil and animals (Baumann 1968, Towner 1996). They are normal 
inhabitants of human skins (Stmlelens 1993, Wise 1990, Allen 1987). The 
contribution of Acinetohacter species to nosocomial infection has been recognized 
and these organisms are now considered to be important nosocomial pathogens, 
particularly in intensive care units (ICUs). In Europe, Acinetohacter spp. account 
for 9% of nosocomial infection in ICUs (Joly-Guillou 1993), with a more 
predominant role in nosocomial pneumonia, particularly ventilation-associated 
pneumonia. The taxonomic confusion and technical difficulties of phenotypic 
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identification methods have thrown doubt on the scanty data published on the 
ecology and epidemiology of the genus. Previous studies rarely distinguished 
groups of the Acb complex found in clinical specimens. In this project, the 
genomic DNA groups of the isolates from different sources will be determined. 
The precise characterization of a large number of acinetobacters from various 
sources would improve our knowledge of the ecological and pathogenic roles of 
different genomic DNA groups in Hong Kong. 
1.5.2 Consideration of taxonomical problems 
A limited and changing classification over the past decade has impeded our 
understanding of ecological and clinical roles of the genus Acinetohacter. More 
recently, genetic methods such as DNA-DNA hybridization and amplified 
ribosomal DNA restriction analysis (ARDRA) technique have divided the genus 
into 19 genomic DNA groups. Although DNA-DNA hybridization is well 
established and considered being a "gold" standard method, it is too laborious and 
therefore performed in the reference laboratory only. In comparison, ARDRA is a 
relatively simple technique, capable of identifying acinetobacters to the genomic 
DNA group level. ARDRA was therefore used as a species identification method 
in this research project. Recently, classification of acinetobacters based on tDNA-
spacer fingerprinting has been reported (Wiedmann 1994, Ehrenstein 1996). This 
seems a simple rapid method but there is a need for further evaluation on 
collections of both clinical and environmental isolates. In this project, the 
usefulness of tDNA fingerprinting was assessed with selected isolates from 
clinical specimens, carriage sites and environmental sources. 
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1.5.3 Characterization of Acinetohacter isolates 
Strains of A baumannii are often considered to be more resistant to antimicrobial 
agents than other genomic DNA groups (Bergogne 1996, Buisson 1990, French 
1980, Joly-Guillou 1991). The published data, however, were based on strains 
almost exclusively isolated from clinical specimens (Buisson 1990), or other 
studies using the phenotypic methods for identification (French 1980, Larson 
1984, Struelens 1993). The information of antimicrobial susceptibility of 
Acinetohacter genomic DNA groups from our region is not clear. In the present 
project, the susceptibility of selected isolates of different genomic DNA groups 
was therefore studied. 
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1.6 Research objectives 
In the present research project, using recently developed molecular identification 
technique, we intended to study the distribution of the Acinetobacter species in 
collections of isolates obtained from different sources: clinical sites, human 
carriage sites, soil samples and vegetables. 
Objectives: 
i. To study the distribution of different species of Acinetobacter in clinical, 
human carriage sites and environmental sources 
a. To cany out a prevalence study of Acinetobacter species in different 
types of clinical specimens received at the Microbiology Laboratory, 
Prince of Wales Hospital, Hong Kong. 
b. To study the distribution of Acinetobacter species in clinical 
specimens, carriage sites and environmental sources. 
c. To use amplified ribosomal DNA restriction analysis (ARDRA) to 
identify the genomic DNA groups of acinetobacters isolates. 
ii. To assess the usefulness of tDNA fingerprinting for identification of 
Acinetobacter species. 
iii. To study the antimicrobial susceptibility of selected isolates of different 
Acinetobacter genomic DNA groups. 
iv. To determine the relationships of isolates of the same genomic DNA 
groups oiAch complex from different sources by biotyping. 
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CHAPTER 2 MATERIALS AND METHODS 
The aim in this project was to study the distribution of Acinetohacter species from 
different sources including clinical specimens, human carriage sites and 
environments. The sample information, sampling duration and isolation procedure 
of these isolates would be described in this section. The clinical isolates of 
Acinetohacter were primarily obtained from the routine clinical laboratory, Prince 
of Wales Hospital, PWH, Hong Kong SAR, China and then stored for further 
investigation in this project. 
2.1 Materials 
2.1.1 Reference strains 
Thirty-five reference strains of Acinetohacter, kindly provided by Dr. T. L. Pitt, 
Laboratory of Hospital Infection, Central Public Health Laboratories, PHLS, 
Colindale, London, United Kingdom with the permission of Dr. L. Dijkshoom, 
Leiden Hospital, Leiden, were used in this project. The reference strains were 
previously identified to DNA groups by DNA-DNA hybridization and 
representing 18 genomic DNA groups. They were used in ARDRA, tDNA 
fingerprinting, phenotypic and biotyping characterization tests. The list of 
reference strains is shown in table 2.1 and their detailed information is in 
Appendix 1. 
The control strains Escherichia coli ATCC 25922, Escherichia coli ATCC 35218 
and Pseudomonas aeruginosa ATCC 27853 were used for the determination of 
minimum inhibitory concentration (MIC). 
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Table 2.1 Information of the reference strains of Acinetobacter 
DNA group (species name) Designation of strain  
1 (A. calcoaceticus) RUH 584, RUH 2203 
2 (A baumannii) RUH872, RUH2207, NCTC 12156丁 
3 RUH 502，RUH2204 
4 {A. haemolyticus) RUH 55, RUH 2213 
5 {A. junii) RUH 204, RUH 2228 丁 
6 RUH 2867 
7 {A. johnsonii) RUH 2232, RUH2855 
8/9 {A. Iwoffii) RUH 551, RUH 2219丁 
10 RUH 2222, RUH 2223 
11 RUH 2860 
12 (A radioresistens) RUH 2225, RUH 2865 丁 
13BJ/14TU LUH 1718, RUH 2216 
13TU RUH 2041, RUH 2210 
14BJ LUH 1726, LUH 1727 
15BJ LUH 1729, LUH 1730 
15TU LUH 1090, LUH 1091 
16 LUH 1731, LUH 1732 
_17 LUH 1735, LUH 1736 
RUH: Rotterdam University Hospital; LUH: Leiden University Hospital; T: Type strain 
2.1.2 Antimicrobial agents and chemicals 
The antimicrobial agents and chemicals used in this study were bought from 
commercial suppliers or provided by the manufacturers. The antimicrobial agents 
applied in this study are listed in table 2.2 and chemicals used in table 2.3. 
Table 2.2 List of antimicrobial agents applied in this study 
Antibiotic name Source  





Ciprofloxacin Bayer, Elberfeld, USA 
Gentamicin Sigma 
Imipenem Merck Sharp and Dohme (MSD), 
Hoddesdon, UK 
Levofloxacin Sigma 
Netilmicin Schering-Plough Corporation, 
Kenilworth, New Jersey, USA. 
Sulfamethoxao le Sigma 
Sulbactam Pfizer, Sandwich, UK.  
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Table 2.3 List of chemicals used in this study 
Chemical name Source 
Absolute alcohol Merck, Frankfuther Strasse, Germany 
Acetic acid Merck 
Adenine 5'-Triphosphate (ATP) Amersham Pharmacia Biotech, Upsala, 
Sweden 
Ammonium chloride Merck 
Ammonium persulphate Sigma, ST, MO, USA 
Ammonium ferric citrate BDH Chemicals Ltd., Poole, UK 
Ammonium acetate Sigma 
Boric acid Sigma 
Bovine serum albumin (BSA) Amersham Pharmacia Biotech 
Bromophenol blue BDH 
Bromothymol blue BDH 
Calcium chloride Merck 
Choroform Merck 
Dithiothreitol (DTT) Amersham Pharmacia Biotech 
Ethylenediaminetetraacetic disodium Amersham Pharmacia Biotech 
salt (EDTA) 
Ethidium bromide Sigma 
Ferric ammonium citrate Merck 
Glycerol Merck 
Guanidium thio cyanate S igma 
Hydrochloric acid Sigma 
Isoamylalcohol Merck 
Lactic acid Merck 
Dipotassium phosphate Merck 
Potassium dihydrogen phosphate BDH 
Potassium nitrate Merck 
Magnesium sulphate BDH 
Phenol red Merck 
Potassium nitrate BDH 
Sarkosyl (N-Lauroyl-Sarcosine) Sigma 
Sodium chloride BDH 
Sodium dodecyl sulphate (SDS) Sigma 
Sodium dihydrogen phosphate BDH 
Sulphanilic acid BDH 
Disodium hydrogen phosphate BDH 
Trisodium citrate BDH 
Tris-base Sigma 
TEMED Amersham Pharmacia Biotech  
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2.1.3 Carbohydrates, enzymes and other materials 
Table 2.4 List of carbohydrates, enzymes and other materials 
Category Name Source 














Enzymes Alu\ Boehringer Mannheim, 
Mannheim, Germany 
Bfa\ New England Biolabs, 
Beverly, USA 
Cfo\ Boehringer Mannheim 
Mbo\ Boehringer Mannheim 
Msp\ Boehringer Mannheim 
Rsa\ Boehringer Mannheim 
BsmaX New England Biolabs 
Taq DNA polymerase Amersham Pharmacia 
Biotech 
Markers 50 base pair ladder Amersham Pharmacia 
Biotech 
100 base pair ladder Amersham Pharmacia 
Biotech 
50 base pair Cy5-labelled DNA Amersham Pharmacia 
ladder Biotech 
ALFexpress™ Sizer® 50-500 Amersham Pharmacia 
Biotech 
X DNA Amersham Pharmacia 
Biotech 
Agarose Gels Seakem® LE agarose FMC Bioproducts, 
Rockland, Maine, USA 
Rapid Gel™ - X L 6% DNA Amersham Pharmacia 
sequencing gel solution Biotech 
Other reagents Loading dye (ALFexpress™) Amersham Pharmacia 
Biotech 
One-Phor-All Buffer Plus Amersham Pharmacia 
Biotech 
PGR reaction buffer Amersham Pharmacia 
Biotech 
Bacterial identification Kit API 2QNE BioMerieux, Lyon, France 
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2.1.4 Commercial media and media prepared manually 
Table 2.5 List of commercial media used in this study 
Commercial media name Source 
Acid casein hydrolysate Oxoid, Basingstoke, Hampshire, UK 
Bacteriological agar No. 1 Oxoid 
Brain heart infusion (BHI) broth Oxoid 
Gelatin Oxoid 
Iso-sensitest (1ST) agar Oxoid 
Lab-Lemco powder Oxoid 
MacConkey agar Oxoid 
Muller-Hinton agar (MHA) Oxoid 
Neutralized soya peptone Oxoid 
Nutrient agar Oxoid 
Peptone Oxoid 
Tryptocasein soy broth (TSB) Oxoid 
Yeast extract Oxoid 
Blood agar base Oxo id 
Media prepared manually 
The Modified Leeds Acinetobacter Medium (MLAM), (Jaward 1994, Chu 1999) 
Bacteriological Agar 10 g 
Acid casein hydro ly sate 15 g 
Neutralized soya peptone 5 g 
Sodium chloride 5 g 
D-(-)-fructose 5 g 
Sucrose 5 g 
D-mannitol 1 g 
Ferric ammonium citrate 0.4 g 
Phenol red 0.02 g 
Distilled water 1 L 
The pH of the medium was adjusted to 7.0. The medium was autoclaved for 15 
min at 121°C and 15 Ib/in^. After cooling to 50 to vancomycin 3ug/ml was 
added. [The concentration was reduced from original formula 10 |j,g/ml (Jaward 
1994) to 3 jug/ml (Chu 1999)]. 
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Acinetohacter Enrichment Broth (AEB) (Dijkshoorn 1987) 
1.5 g KH2PO4 was dissolved in 400ml distilled water (solution A) 
16.5 g Na2HP04.2H20 was dissolved in 500ml distilled water (solution B) 
5 mg FeS04.7H20 was dissolved in 10ml distilled water (solution C) 
MgS04 7H2O 0.2 g 
NH4CI 2.0 g 
CaCl2 10 mg 
Sodium acetate 2.0 g 
Solution C 1 ml 
The above was added to solution A (each component was dissolved before adding 
the next). Then solution B was added while stirring. Distilled water was added to 
960 ml, the pH was then adjusted to 7.5 and made up to 1000 ml. The medium 
was autociaved for 15 min at 121°C and 15 Ib/in^. The medium was tested both 
for sterility and its nutritional quality with reference to Acinetohacter strains. 
Tween 80 medium nutrient agar (Cowan 1993) 
Peptone 10 g 
NaCl 5g 
CaCl2.2H20 0.1 g 
Agar 20 g 
Distilled water 1 L 
The pH of the medium was adjusted to 7.4, then autociaved for 15 min at 121°C 
1 J 」•_ 
and 15 lb/in . Sterile Tween 80 was added aseptically at a final concentration 1% 
(w/v). 
Carbon source utilization tests for Biotyping (Cmze 1979) 
Cruze minimal salt medium 
K2HPO4 10 g 
NaH2P04 5 g 
(NH4)2S04 2g 
MgSCV7H2O 0.2 g 
CaCl2 2H20 0.001 g 
FeS04 7H20 0.001 g 
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The above medium was adjusted to one liter with distilled water. The pH of the 
final solution was 7.0, and then the solution was autoclaved for 15 min at 12rC 
and 15 Ib/inl 
The five carbon sources used for biotyping were levulinate, citraconate, L-
phenylalanine, 4-hydroxybenozoate and L-tartrate. The carbon sources were 
sterilized by filter sterilization. The Filter sterilized carbon sources were added to 
the Cruze minimal medium at a final concentration of 0.1% (w/v). The medium 
was dispensed as 3ml per tube. 
Huge and Leifson's (OF) medium (Cowan 1993) 
Peptone 2 g 
Sodium chloride 5 g 
Dipotassium phosphate 0.3 g 
Bro mo thymol blue 0.03 g 
Agar 3 g 
Distilled water 1 L 
The final pH was adjusted to 7.1. The medium was autoclaved for 15 min at 
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1 2 r c and 15 Ib/inl Then the medium was cooled and 10% glucose solution was 
added to a final concentration of 1% glucose. The medium was dispensed in 3 to 4 
ml per 13 by 100 mm test tube. 
Nitrate reduction medium (Cowan 1993) 
Potassium nitrate, KNO3 0.2 g 
Peptone 5 g 
Distilled water 1 L 
The medium was dispensed in tube in 5 ml amounts and autoclaved for 15 min at 
n r c and 15 Ib/inl 
Test reagent: 
Nitrate 1: 8 g of sulphanilic acid was dissolved in 1 L of 5 N acetic acid 
Nitrate 2: 5 g of a-naphthylamine was dissolved in 1 L of 5 N acetic acid 
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Transformation (Juni 1972) 
Lysis solution: 
Trisodium citrate-ZHiO 0.44 g 
Sodium chloride 0.88 g 
Sodium dodecyl sulfate 0.05 g 
Distilled water 100 ml 
The solution was mixed and autoclaved for 15 min at 121�C and 15 Ib/in^. 
Indicator medium: 
Lactic acid 4 g 
Casein hydrolysate 16 g 
Yeast extract 0.5 g 
KH2PO4 1.5 g 
Na2HP04 13.5 g 
MgS04 0.1 g 
NH4CI 2 g 
CaCli 1% solution 1 ml 
FeSO/ 7 2O fresh solution 0.5 ml 
The above chemicals were added into 800ml distilled water until completely 
dissolved. Then the solution was adjusted to IL with distilled water and 
autoclaved for 15 min at 121°C and 15 Ib/inl 
Indicator agar plate: 
One volume of liquid indicator medium was added to an equal volume of melted 
sterile 3% (w/v) bacteriological no. 1 agar, mixed and poured. The plates 
(20ml/plate) were stored at 
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2.1.5 Reagents 
0.5 M EDTA 
0.5 M NazEDTA2H2O and 10 M NaOH (pH 8.0) 
Buffered salt solution 
150 mM NaCl/10 mM EDTA (pH 8.0) 
1 M Tris/HCl 
1 M Tris and concentrate HCl (pH 7.6) 
IPX TE 
100 mM Tris/10 mM EDTA (pH 7.6) 
IPX TBE 
0.89 M Tris/ 0.89 M boric acid/ 20mM EDTA (pH 8.0) 
5QXTAE 
2 M Tris/ Acetate/ 50 mM EDTA 
Sample buffer 
25% (v/v) glycerol, 0.5% SDS, 50 niM EDTA, 0.05% (w/v) bromophenol blue 
Ammonium acetate (NEUAc) 
7.5 M ammonium acetate 
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2.1.6 Instruments and Software used in this study 
Name Manufacturer 
Instruments 
Automatic multiple inoculator MIC Dynatech, Denley, UK 
2000 
GNA-100 and 200 gel apparatus Amershem Pharmacia Biotech, Uppsala, 
Sweden 
Bio-Rad 200-200V power supply BioRad, California, USA 
Gel documentation system Amershem Pharmacia Biotech, Uppsala, 
(ImageMaster VDS) Sweden 
Thermal controller (Gene Amp PGR Perkin Elmer, USA 
system 9600) 
Automated laser DNA sequencer Amershem Pharmacia Biotech 
(ALFexpress) 
Centrifuge MSE Micro Centaur Sanyo, UK 
Software 
ALFWIN Amershem Pharmacia Biotech 
GelCompar Applied Maths, Kortrijk, Belgium 
SPSS version 8.0 Prentice Hall, UpperSaddle River, New 
Jersey 
Epi Info version 5.01b CDC, Epidemiology Program Office,  
Atlanta, Georgia  
2.2 Methods 
Isolates collected from the clinical laboratory, PWH 
The identity of isolates obtained from the clinical laboratory was re-confirmed to 
the genus level according to the criteria in this project (see Section 2.3) before 
storage in NA slope for examination later. 
2.2.1 Routine laboratory collection 
Clinical isolates of Acinetobacter spp. were obtained from the routine clinical 
laboratory, Prince of Wales Hospital (PWH), Hong Kong SAR, People's Republic 
of China, from i f ^ Oct. 98 to Dec. 98. During this period, all isolates of 
acinetobacters from specimens were collected. The isolates were identified in the 
routine laboratory by standard biochemical tests including Gram stain, oxidase 
test, OF test and Microbact 12E (Medvet). 
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2.2.2 Blood culture collection 
All Acinetobacter spp. isolated from blood cultures by the routine clinical 
laboratory, PWH, from Jan. 1997 to 31'' Aug. 1998, were collected. The 
isolates were identified in the routine laboratory by standard biochemical tests 
including Gram stain, oxidase test, OF test and API 20NE (BioMerieux). 
Isolation of Acinetobacter in this project 
In this project, surveillance screening on clinical specimens was carried out to 
study the prevalence of Acinetobacter spp. in clinical specimens. Isolation of 
acinetobacters from human carriage sites, environmental sources, vegetables and 
soil were also carried out. 
All Acinetobacter isolates in this project were identified to genus level by the 
standard biochemical tests and transformation assay (see section 2.3). Unless 
otherwise stated, the genomic DNA groups of all isolates were determined by 
ARDRA method (see section 2.4) 
2.23 Human carriage site collection 
Skin and mucous membrane carriage of Acinetobacter spp. was studied in healthy 
volunteers and in patients. 
Healthy volunteers subjects 
Medical Students 
First-year medical students in 1997 were recruited as healthy community subjects. 
They had pursued their studies only at the campus of the Chinese University of 
Hong Kong, far from the hospital environment. 
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Student Nurses 
The residential nursing course at PWH is divided into a 14 to 22 weeks ward 
block for clinical work and 7 to 12 week study block at the school. A class of new 
nursing students in 1997, class no. 42 (N42), was recruited as healthy community 
subjects as they were engaged in a study block at the school of nursing and had 
not been exposed to the ward environment. The sampling of this group was done 
during the first 48 h of their arrival at the school. 
Patients subjects 
Acute patients: Patients from two acute medical wards at PWH who did not have 
a history of antibiotic therapy, and who had not been admitted to hospital during 
the preceding 14 days, were recruited within 2 days of their admission. 
Chronic patients: Patients who had been hospitalized at the Shatiii Hospital, 
Shatin, Hong Kong, for at least 7 days were recruited in the study. Shatin 
Hospital receives convalescent patients from PWH. 
Sampling 
The samples were taken from the study subjects by members of the Microbiology 
laboratory. 
Having obtained informed consent from the subjects, cotton wool swabs 
moistened with sterile saline (except for throat swabs) (Venturi Transystem) were 
used to obtain samples from five sites on the subjects: throat, hairline, anterior 
nares, groins and fourth-toe webs. The same swab was used on both sides for each 
of the last three sites. 
The swabs were either processed on the same day or stored at 4°C for 18 h before 
further laboratory examination for this project. 
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Isolation 
The swab was vortexed in 1ml sterile peptone water for one minute and the 
deposit resuspended. lOOjil of the peptone water was inoculated on to the 
Modified Leeds Acinetobacter Medium (MLAM) agar and spread with a sterile 
glass rod. All plates were incubated at 30�C in air for 48 h. Typical colonies were 
picked for identification. 
2.2.4 Surveillance screening of clinical specimens 
Duration 
Samples were collected during two periods, one in the winter Jan 1997) 
and one in the summer - Aug 1997), so that seasonal variation in the 
prevalence of acinetobacters in clinical specimens in Hong Kong could be 
investigated. 
Isolation 
All routine clinical specimens, with the exception of blood cultures were screened 
for the presence of acinetobacters after processing by the routine clinical 
laboratory, PWH. 
Stool and respiratory specimens, including sputum, tracheal aspirate, bronchial 
aspirate and bronchial alveolar larvage (BAL), were inoculated on to a half-plate 
of MLAM agar using a swab. Throat, rectal and other swab specimens were 
directly inoculated on to a half plate of MLAM agar. The sediments, after 
centrifliged at 1500 g for 15 min, of body fluids, i.e. pleural, peritoneal and knee 
joint fluids, were inoculated on to a half-plate of MLAM agar. For urine 
specimens, including MSU, CSU, bag and suprapubic urine, a paper strip method 
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was applied. A standard volume paper strip was dipped into the urine and then 
inoculated onto an eighth ML AM plate (Pezzlo 1998). 
All inoculated plates were incubated at SO^ 'C in air for 48 h. The plates were first 
examined after 24 hours, and typical colonies were picked for identification. The 
plates were re-examined after further 24 h incubation. 
2.2.5 Environmental samples - vegetables 
Period of collection 
Different vegetables, including Chinese celery, Leek, Spring onion, Spinach, Pak 
choi, Coriander, Purslane, Choi sum and Sweet beans, were purchased on 41 
occasions throughout 12 months in 1997. Samples were chosen to represent 
vegetables commonly grown and consumed in Hong Kong. 
Isolation 
Vegetables were cut into small pieces and about 5 g weighed in a sterile container. 
20 ml of sterile distilled water was added into the container and shaken. 10 jil of 
the mixture was inoculated onto a MLAM agar plate and incubated at 30°C in air 
for 48 h. Typical colonies were picked for identification. 
2.2.6 Environmental samples - soil 
Period of sampling 
To investigate the distribution of acinetobacters in the natural soil environment in 
Hong Kong, collections were carried out in the summer (Sept 1998) and the 
winter (Jan 1999). 
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Selection of collection sites 
Ten collection sites (Table 2.6) were chosen in this study. Six collection sites 
(Collection Site 2, 5, 7，8, 9,10) are in urban areas and four (Collection Site 1，3, 
4, 6) in rural areas of Hong Kong (see map in Appendix 2). For urban sites, 
samples were taken from an urban park near residential properties. 
Approximately 500,000 people lived in collection site 9, while approximate 
300,000 people lived in the other sites. For the rural sites，samples were taken 
from hill slopes or country parks, at least 2 km from residential areas. The chosen 
sampling sites represented soil environments of the major urban and rural areas in 
Hong Kong. 
Table 2.6 List of collection sites of soil sample 
No. Collection site Description Type 
1 Tsuen Wan, mountain slope Mountain in New Territories Rural 
2 Tsuen Wan city Kowloon West Urban 
3 Tai Mo Shan country park Mountain in New territories Rural 
West 
4 Tsing Yi mountain slope Mountain in Tsing Yi Island Rural 
5 Tsing Yi city Tsing Yi Island Urban 
6 Shatin, CU campus, Mountain in New Territories Rural 
mountain slope East 
7 Shatin city New Territories East Urban 
8 Wai Chai Hong Kong Island Urban 
9 Mongkok Kowloon Central Urban 
1 0 Cheung Sai Wan Kowloon Central Urban 
Collection of soil samples 
Three random samples were taken in each collection site during the summer 1998 
and the winter 1999. For each collection site, the same spot was sampled for both 
seasons. An alcohol-cleaned digger was used to collect approximately 10 g of soil 
at 10 cm below the ground level. The sample was then placed in a sterilized bag 
and transported to the laboratory immediately. The samples were stored at -20°C 
until examination. 
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Enrichment method for isolation 
Because the Acinetohacter count in the soil was low, -0.001% of the total aerobic 
population (Baumann 1968), a selective enrichment cultivation method using 
Acinetohacter Enrichment Broth (AEB) was applied in this project. 
About 1 g of soil sample was weighed in a sterile container. Then 10ml of sterile 
distilled water were added to the container and mixed gently to make a soil 
suspension. The soil suspension was centrifliged at 800g for 1 min or left to stand 
at room temperature for 30 min for sedimentation of the coarse soil material. After 
sedimentation, 2.5ml of the supernatant were transferred into 10 ml of 
Acinetohacter Enrichment Broth (AEB) and incubated at 30°C in air for 48 h with 
vigorous aerobic shaking. Then 10 p.1 of neat and 1 in 10 dilution of the incubated 
broth were inoculated onto ML AM agar. The plates were incubated at 30°C in air 
for 48 h. Typical colonies were picked for identification. 
2.3 General bacteriological techniques for genus identification 
The identification of the genus Acinetohacter was based on the following criteria 
(Cowan 1993): Gram-negative coccobacilli, oxidase-negative, non-fermenting in 
0/F test, non-motile in hanging drop preparation, aerobic growth, catalase-
positive, nitrate reduction negative, and hydrolysis of Tween 80 mostly positive. 




A strip of filter paper was soaked with a freshly prepared oxidase reagent (0.1 g of 
Tetramethyl-p-phenylene-diamine dihydrochloride in 10 ml distilled water). The 
test colony was picked up with a platinum loop and smeared over the moist area. 
A positive reaction is indicated by an intense deep-purple colour appearing within 
5-10 s, a delayed positive reaction by coloration in 10-60 s，and a negative 
reaction by the absence of colour or by coloration after 60 s. 
Catalase Test 
A single colony of the test organism from a non-blood containing agar was 
emulsified in a drop of catalase reagent (3-6% Hydrogen peroxide) on a glass 
slide. Immediate bubbling indicates a positive catalase test. A false positive 
reaction may be obtained if the culture medium contains catalase (e.g. blood agar), 
or if an iron wire loop is used. 
Motility Test 
Young broth culture of the organism was examined in "hanging drop” 
preparations after incubation at 30°C for 4 h. Motile organisms move about in the 
field, and this is to be distinguished from Brownian movement, which is an 
oscillatory movement possessed by all small bodies suspended in fluid. 
Oxidation-fermentation (OF) test 
The test colony was stabbed lightly into two tubes of the medium. One of the 
tubes was covered with paraffin oil and the tubes were incubated at 30°C in air for 
48 h. Acid formation only in the open tube indicates oxidative utilization of 
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glucose. Acid formation in both the open and sealed tubes indicates a fermentative 
reaction 
Nitrate reduction test 
The test organism was inoculated into the medium tubes and was incubated at 
30°C in air for 48 h. After incubation, 1 drop of each Nitrate 1 and 2 were added 
to the tube. A red colour developing within a few min indicates the presence of 
nitrite and hence the ability of the organism to reduce nitrate. 
Tween 80 test 
The test organism was streaked on the surface of Tween 80 Agar and incubated at 
30®C in air for 48 h. Hydrolysis of Tween was indicated by an opaque halo of 
precipitation around the growth. 
Transformation assay (Juni 1972) 
Preparation of crude transforming DNA: 
A loopfiil of cell paste of the test organism from a 30^C overnight Mueller Hinton 
agar culture was suspended in 0.5 ml of the lysis solution. The suspension was 
mixed well with a Vortex mixer and heated in a 60°C water bath for 2 h. The 
sterility of the crude DNA solution was checked by subculturing onto a NA plate 
and incubated at 30°C for 24 h. 
Transformation of auxotrophic tester strains trpE27: 
A loopful of the auxotroph trpE27 was inoculated onto 6 segments of an indicator 
plate divided into 8 equal segments. A loopflil of the crude transforming DNA 
was spread on one of the 6 segments and mixed with the auxotroph. The 
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auxotroph strain was plated on the 7th segment as the negative growth control and 
Type strain of Acinetohacter baumannii (NCTC 12156) was plated on the 8th 
segment as the positive growth control. All plates were incubated at 30°C for 48 h. 
Interpretation: 
A positive result control was obtained when auxotroph trpE27 ceils were mixed 
with DNA from A. baumannii type strain, no growth was seen when cells were 
mixed with DNA from an unrelated organism. Auxotrophic trpE27 cell paste 
treated with DNA from an authentic strain of Acinetohacter resulted in the 
appearance of protrophic transformant colonies. 
2.4 Molecular techniques used for the delineation of genomic DNA groups 
2.4.1 Amplified ribosomal restriction DNA analysis (ARDRA) 
The ARDRA method was performed as described by Vaneechoutte et al,, 1995 
with minor modifications. 
Bacterial DNA template preparation (Quick boil lysis) 
Bacteria were grown on Mueller Hinton agar at 30°C for 24 or 48 h. A loopful of 
2-5 colonies was suspended in 300 |il sterile double distilled water, then boiled at 
lOO^C for 5 min. After boiling, the suspension was agitated thoroughly and 
centrifuged for 1 minute in a high-speed (13000-rpm) microcentrifuge to spin 




A 5 iLil of the DNA template was mixed with a reaction mixture containing 0.5 
Unit of Tag DNA Polymerase, 0.2 i^M of each primers (ARDRAl: 3TGG CTC 
AG A TTG AAC GCT GGC GGC - 5' and ARDRA 2: 5 TAG CTT GTT ACG 
ACT TCA CCC CA - 3,), 100 i^M of deoxynucleoside triphospates (dNTPs) and 
IX PGR buffer (10 mM Tris-HCl, pH二8.3，1.5 mM MgClz, 50 mM KCl). The 
final volume of the reaction mixture was 50 ]li1. 
The reaction cycle was performed in a thermocycler (Roche 9600) with an initial 
denaturation of 5 min at 95�C followed by 35 cycles of 45 s at 95°C，45 s at 58'C 
and 1 min at 72°C, and a final extension of 7 min at 72°C. 
Agarose gel electrophoresis 
To check for the presence of specific PGR products, amplicons were separated 
electrophoretically on 1% agarose gel containing ethidium bromide (50 ng/ml). 5 
]Lil of amplicons mixed with 2 jil 5X loading buffer were loaded and 
electrophoresed at 100 V in IX TBE buffer system for 1 h. A 100 bp size marker 
was loaded in each run for size comparison. The gel was examined under ultra-
violet trans-illuminator. The length of amplicons was estimated to be about 1,500 
bp. 
Restriction enzyme digestion 
The amplicons were initially subjected to the digestion of 5 restriction enzymes, 
Cfo\ (GCGC), Alu\ (AGCT)，Mbo\ (GATC), Rsa\ (GTAC) and Msp\ (GATC). 
Further digestion with Bsmal and Bfa\ was also performed when necessary. 
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For each restriction reaction 3 to 10 of amplicons were mixed with the 
restriction mixture containing 1 of the restriction enzymes with 1.5 )il of their 
reaction buffer and 12.5 distilled water. The volume of amplicons used in the 
reaction was based on the visually observed IJV fluorescence intensity of the 
amplified rDNA fragment. The total volume of the restriction reaction mixture 
was about 20 [i\ and the mi N aid the nixtu e wb i T for 1.5 h. 
After the restriction digestion, the restriction fragment patterns were examined by 
gel electrophoresis. 10 of each restriction mixture mixed with 2 jul 5X loading 
buffer were loaded in a 2% agarose gel containing ethidium bromide (50 ng/ml) 
and electrophoresed at 100 V in IX TBE buffer system for 1.5 h. A 100 bp size 
marker was loaded in each run for size comparison. The gel was examined under 
UV fluorescence. 
Interpretation 
The restriction patterns generated with the use of the five restriction enzymes 
were coded following the schemes of Vaneechutte et al. (1995) and Dijkshoom et 
al. (1998) (Appendix 3). The combination of five restriction patterns constitutes 
an ARDRA profile. By matching this ARDRA profile with the existing database 
of ARDRA profiles (Appendix 4), an identification of genomic DNA groups can 
be obtained. Any isolate with unmatched or novel ARDRA profiles was classified 
as ARDRA unclassifiable acinetobacters (AUA). 
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2.4.2 Characterization of acinetobacters by tRNA spacer (tDNA) 
fingerprinting analysis 
The tDNA fingerprinting method was performed as described by Ehrenstein et al 
(1996) with minor modifications. 
Bacterial DNA template preparation (Quick boil lysis) 
Same as ARDRA method (see section 2.4.1) 
Primers 
Primers designed to amplify the spacer regions of tDNA clusters were used in 
tDNA fingerprinting analysis (Welsh 1991). Two oligonucleotide primers for 
tDNA outward spacer amplification, which were consensus sequences derived 
from the tDNA 3’ and 5' ends were used and their sequences were as follows: 
T3A, 5,-GGG GGT TCG AAT TCC CGC CGG CCC CA-3, and 
T5B, 5,-AAT GCT CTA CCA ACT GAA CT-3'. 
Both primers were 5’ end labelled with laser fluorescent chemical Cy-5 during 
custom synthesis (Sigma-Genosys, UK.) 
PGR 
One microliter of DNA template was mixed with reaction mixture containing 0.6 
Unit of Taq DNA Polymerase and 0.1 mM of each primer, T3A and T5B, 200 |_iM 
of deoxynucleoside triphospates (dNTPs) and IX PGR buffer (10 mM Tris-HCl, 
pH=8.3, 1.5 mM MgC^, 50 mM KCl). The final volume of the reaction mixture 
was 25 fil. The reaction cycle was performed in a ther mo cycler (Roche 9600) 
with an initial denaturation of 2 min at 94°C followed by 45 cycles of 40 s at 
94°C, 40 s at 50�C and 2 min at 72�C, and a final extension of 3 min at 72°C. 
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DNA Fragment analysis 
Amplicons were analyzed with the automated laser DNA sequencer 
(ALFexpress). DNA fragments were separated electrophoretically through 6% 
Gene-PAGE-PLUS 7 M urea denaturing poly aery lamide gel. To prepare a loading 
sample, 2 of 1 in 5 diluted amplicons was mixed with 7 ]li1 spiked loading dye 
which contained 3 }il loading dye, 2 ii\ each of the two internal size markers, 114 
bp and 821 bp. The loading sample was heated at 95�C for 2 min, then cooled in 
ice and loaded to the gel immediately. The gel was run in 0.5X TBE buffer with 
electrophoresis condition at 1500 V，25 mA and 25 W for 1000 min at 55T. 
Quality control 
Reference Acinetohacter strains: 
All the thirty-five reference Acinetohacter strains were characterized by tDNA 
fingerprinting. 
Internal reference strains: 
Type strain of Acinetohacter baumannii (NCTC 12156) was tested in each run as 
the internal reference strain for inter-gel standardization. 
External and internal size markers: 
Cy5' labelled 50-500 bp were loaded at least three times into the same gel as an 
external size marker for intra-gel standardization. The two markers, 114 bp and 
821 bp, were added to each sample as internal size markers for correction of 
minor variation in migration and gel distortion. 
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Data analysis 
The DNA fingerprints generated by ALFexpress were stored as image files (.alx) 
in ALFWIN. They were then converted to another format of image file (.tif) for 
further processing by GelCompar. After the aligmnent of DNA fragments with 
external and internal markers and automatic background subtraction, a normalized 
gel image was generated. 
2.5 Biotyping of Acinetobacter spp. 
Procedure 
The biotyping method was based on the utilization of five carbon sources, 
levulinate, citraconate, L-phenylalanine, 4-hydroxybenozoate and L-tartrate. A 0.5 
McFarland standard of the test organism was prepared. Then each tube containing 
the carbon source was inoculated with 0.1 ml of the bacterial suspension. The 
inoculated tubes were incubated at 30°C. Growth was examined after 1 and 3 days 
of incubation. Any growth observed was recorded as positive. 
Interpretation 
The biotyping scheme, Table 2.7, was based on the scheme developed by Bouvet 
et al. (Bouvet 1987, Bouvet 1990). The biotypes were numbered according to the 
growth patterns shown in Table 2.7. Any unclassified biotype pattern was 
assigned a new biotype numbers. 
Table 2.7 Classification scheme of Biotyping 
Growth on 1 2 3 4 5 6 7 8 9 1 0 11 12 13 1 4 ~ 1 5 1 6 1 7 18 19 
Levulinate + + + + - - - - - - - - - + + + _ + 
Citraconate - - - - + + + - - - - - + - - + - - + 
L-Phenylalanine + + + - + + + + + + - - - - + + - - + 
4-Hydroxybenzoate + + - - + + - + + - + + + - + - + + 
L-Tartrate + - - - + - - + - - - - - - + + + + -
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2.6 Mmimum Inhibitory Concentration (MIC) 
The agar dilution method was used to determine minimum inhibitory 
concentrations (MICs) of acinetobacters against 11 antimicrobial agents. The 
procedures of agar dilution method were based on the National Committee for 
Clinical Laboratory Standards (NCCLS 1999a). 
Procedure: 
Each tested organism was inoculated into 10 ml BHI broth and incubated at 30°C 
for 4 h to reach the late exponential phase. The bacterial suspension was adjusted 
to 0.5 McFarland standard by using 0.9% saline. Inocula of lO^ CFU/spot were 
inoculated with a multipoint inoculator onto Mueller Hinton agar (MHA) 
containing serial two-fold dilutions of antibiotics (Table 2.8). The plates were 
incubated at 30°C for 24 h. The MIC was defined as the lowest concentration that 
inhibited visible growth. Control strains Escherichia coli ATCC 25922, 
Escherichia coli ATCC 35218 and Pseudomonas aerginosa ATCC 27853 were 
included in each batch of MICs testing. MIC values were interpreted as sensitive 
(S), intermediate (I) or resistance (R) according to the breakpoint values for 
Acinetobacter as recommended by National Committee for Clinical Laboratory 
Standards (NCCLS 1999b). 
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Table 2.8 Range of concentrations of antimicrobial agents used and their 
breakpoint 
Antimicrobial Concentration range Breakpoint values* 
agents tested (mg/L) S R 
3-Lactams 
Ampicillin 0.125-64 <8 >32 
Sulbactam 0.06 — 32 <4 >16 
Cefepime 0.125-64 <8 >32 
Ceftazidime 0.125-64 <8 >32 
Aminoglycosides 
Amikacin 0.125-32 <16 >32 
Netilmicin 0 .06-32 <12 >32 
Gentamicin 0.125 - 3 2 <4 >8 
Quinolones 
Ciprofloxacin 0.06-256 <1 >4 
Levofloxaciii 0.007 — 16 <2 >8 
Carbapenems 
Imipenem 0.06 — 16 <4 >16 
Others 
Tetracycline 0.25 - 64 <4 >16 
* National Committee for Clinical Laboratory Standards (NCCLS 1999b), except 
the breakpoint for sulbactam (Kuan 1994). 
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CHAPTER 3 DISTRIBUTION OF ACINETOBACTER SPECIES 
3.1 Results 
3.1.1 Isolation of acinetobacters from surveillance screening of clinical 
specimens 
To investigate the prevalence of Acinetohacter species in clinical samples in Hong 
Kong, surveillance screening of clinical specimens was carried out in the 
Department of Microbiology, Prince of Wales Hospital (PWH), Hong Kong, 
China. Two sampling periods were included iii the study, to January 1997 
(winter) and to August 1997 (summer). The details of the study are 
described in Section 2.2.1. 
A total of 2,734 and 2,864 specimens were screened in the winter and the summer 
periods, respectively. All types of clinical specimens except blood cultures were 
screened. Acinetobacters isolated from blood cultures within the study period 
were collected from the routine laboratory. The number of specimens in these two 
collections was comparable. Table 3.1 shows the source and the number of 
clinical specimens examined, and the positive isolation rates. In the winter period, 
63 isolates of acinetobacters were isolated and 69 isolates in the summer period. 
The prevalence of Acinetohacter species in the two seasons was similar, about 
2.4%. The overall isolation rate from respiratory specimens was the highest, 
accounting for 11.1% (58/522), this is significantly higher than those from all 
other specimen sites (Chi Square test, P < 0.005,). There is no significant 
difference in the isolation rates of respiratory specimens of the two seasons 
(34/325 versus 24/197, Chi Square test, P = 0.33). The isolation rates from urine 
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(0.5%. 6/1173) and blood culture specimens (0.9%, 18/2063) were low. No 
acinetobacters were isolated firom stool specimens in this study. 
Table 3.1 shows the results of positives for acinetobacters by screening and the 
positive specimens reported by the routine laboratory. For comparison, results of 
throat swabs were excluded because Acinetobacter spp. was not reported by the 
routine laboratory. There is a significant difference between the number of 
positive specimens obtained by screening and that reported by the routine 
laboratory (winter: 63/2,734 vs 25/2,734, Chi Square test, P < 0.001; OR, 2.56; 
95% confidence limit, 1.57 to 4.19; summer: 69/2,864 vs 20/2,864, Chi Square 
test, P < 0.001; OR, 3.51; 95% confidence limit, 2.08 to 5.98). The increase in the 
positives by screening was seen mainly in respiratory specimens. There was a 5 
fold increase in the winter period and 8 fold increase in the summer period. For 
other specimens, the increase was 1.4-2.3 fold. The screening positive rate of 
respiratory specimens was significantly higher than that of laboratory reported 
results in both seasons, in the winter (34/325 vs 7/325, Chi Square test, P < 0.001; 
OR, 5.31; 95% confidence limit, 2.21 to 13.34) and the summer (24/197 vs 3/197, 
Chi Square test, P < 0.001; OR, 8.97; 95% confidence limit, 2.51 to 38.09). For 
urine, superficial and deep wound specimens, there is no significant difference 
between the screening positives and laboratory reported positives in the two 























































































































































































































































































































































































































































































































































































Unexpected loss of acinetobacters during storage of isolates 
At the beginning of the surveillance screening study, once the genus had been 
confirmed, acinetobacters were stocked in nutrient agar (NA) slopes at room 
temperature. Unfortunately, when the organisms were subcultured for further 
investigation, an unexpected high rate of loss of isolates was observed. Seventeen 
percent (11/63) of acinetobacters in the winter and 20% (14/69) in the summer 
collections failed to grow. In the winter collection, only one of the 11 
acinetobacters failed to recover from subculture was reported by the routine 
laboratory, but 3 of the 14 isolates that failed to recover from subculture were 
reported in the summer collection. The winter collection was selected for the 
distribution study. 
Distribution of Acinetobacter species in the winter collection 
A total of 52 of 63 isolates were successfully recovered from stock cultures and 
classified by ARDRA. Table 3.2 shows the distribution of different genomic DNA 
groups by specimen sites. Of these 52 isolates, only six known genomic DNA 
groups were found, namely A. baumannii (Genomic DNA group 2), 3, 13TU, 10, 
16 and 17. A. haumannii accounted for 25% (13/52), genomic DNA group 3 
accounted for 19.2% (10/52) and genomic DNA group 13TU accounted for 15.4% 
(8/52). In total, Acb complex accounted for 59.6% (31/52) of the total isolates, but 
no genomic DNA group 1 (A. calcoaceticus) was found. A total of 15 isolates 
(28.8%) of acinetobacters was unclassifiable by ARDRA and assigned as AUA 
(see section 2.4.1). Twelve of them (23%) had the same unclassifiable ARDRA 
patterns [111(1+2)1] and were designated as U54. 
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Table 3.2 Distribution of Acinetohacter genomic DNA groups in the 1997 winter 
collection 
Number of isolates belonging to genomic DNA groups 
Acb complex AUA 
Specimen 2 3 13TU 10 16 17 U54 U' Total 
- o 2 
Blood culture ^ 
Urine 1 1 1 1 5 
Respiratory tract 7 6 6 \ 2 2 24 
Throat swab 1 1 2 
Superficial Wound 4 1 1 8 14 
Deep Wound 1 1 
Ear swab 1 1 
Eye swab 1 1 1 2 
Others" 1 1 
Total 13 8 10 2 1 3 12 3 52 
#Others included bile, CAPD fluid, catheter tip and tissue. 
AUA: ARDRA unclassified acinetobacters, the ARDRA patterns of AUA referred to appendix 4. 
U': Unclassifiable ARDRA patterns with only one isolate. 
3.1.2 Isolation of acinetobacters from routine laboratory specimens 
The study was carried out from Oct to Dec 1998. During this period, 41 
isolates of acinetobacters were reported by the routine laboratory where a total of 
12,474 specimens were processed. Table 3.3 shows the distribution of 
Acinetohacter species in routine clinical specimens. Five isolates of acinetobacters 
were obtained from blood cultures of 5 patients (0.23%). Acinetobacters were also 
reported in 10 of 338 (3.0%) deep wound swabs, 10 of 1633 (0.6%) respiratory 
specimens, 3 of 901 (0.3%) superficial wound swabs and 4 of 415 (1,0%) other 
specimens (bile, CAPD fluid, eye swab, tissue and catheter tip). Of the 41 
acinetobacters, only 3 known genomic DNA groups (2, 3 and 13TU) were found, 
accounting for 88.8% (36/41) of all isolates. Five isolates (12.2%) were 
unclassified by ARDRA and had 5 different ARDRA patterns. 
49 
Table 3 3 Distribution of Acinetohacter genomic DNA groups in routine clinical 
specimens 
Number of 
Specimen Isolates belonging to genomic DNA 
groups (o/o) 
Specimen examined positive (%) 2 3 13TU AUA 
Blood culture 2221 5 (0.23) 3 1 1 
Urine 4817 7 (0.01) 2 4 1 
Respiratory tract 1633 10 (0.6) 2 3 3 2 
Body fluid 2149 2 (0.05) 1 1 
Superficial wound 901 3(0.3) 2 1 
Deep wound 338 10 (3.0) 5 2 2 1 
Others* 415 4(1.0) 2 2 
Total 12474 41 (0.3) 14 (34.1) 15 (36.6) 7(17.1) 5(12.2) 
*Others included bile, CARD fluid, eye swab, tissue and catheter tip. 
AUA: ARDRA unclassified acinetobacters. 
3.1.3 Distribution of Acinetohacter genomic DNA groups in all clinical 
specimens 
In this project, there were two sources of isolates of Acinetohacter species from 
clinical specimens, (1) Surveillance screening collection, (2) Routine laboratory 
collection. However, some isolates from surveillance screening were not reported 
by the routine laboratory as they were not considered to be of clinical 
significance. To obtain data on a larger collection of specimens and over longer 
periods of time, the results of routine laboratory collection isolates and the 
reported isolates from surveillance screening were combined together to obtain a 
picture of the distribution of Acimtobacter genomic DNA groups in clinical sites. 
Table 3.4 shows the distribution of Acinetohacter genomic DNA groups in clinical 
specimens of laboratory reported and non-reported isolates. A total of 65 isolates, 
24 from surveillance screening collection and 41 from routine laboratory 
50 
collection, of acinetobacters were studied. The occurrence of A. haumannii and 
genomic DNA groups 3 was similar, accounting for 31% (20/65) and 29% (19/65) 
respectively. No A. calcoaceticus (genomic DNA group 1) was found. A total of 
12 (18.4%, 12/65) were unclassified by ARDRA (AUA), giving 6 different 
imclassifiable ARDRA patterns. There were 7 isolates of U54 and 5 isolates 
belonging to 5 other unclassified genomic DNA groups. 
Table 3.4 Distribution of Acinetobacter genomic DNA groups in clinical 
specimens of laboratory reported and non-reported isolates 
Number of isolates belonging to genomic DNA group 
Acb complex AUA 
Specimen ~ 2 3 i m T 10 16 17 U 5 4 U ^ Total 
Blood culture 3 1 2 1 7 
Urine 3 5 1 9 
Respiratory tract 3 5 5 1 2 16 
Deep wound 1 1 
Superficial wound 10 3 3 5 2 23 
Others 3 3 2 1 9 
Reported Total 20 19 12 2 7 5 65 
Non-reported 7 4 5 1 3 8 28 
AUA: ARDRA unclassified acinetobacters, which ARDRA patterns was referred to appendix 4. 
U' included 5 unclassifiable ARDRA patterns with only one isolate. 
Others included bile, CAPD fluid, tissue, eye and ear swabs. 
3.1.4 Isolation of acinetobacters from blood culture 
Blood culture isolates obtained from Jan 1997 to Aug 1998 by the routine 
laboratory were studied. During this period, a total of 37,520 sets of blood culture 
were received and 125 isolates of acinetobacters (0.33%) were obtained. Of these 
125 isolates, 121 isolates were identified to genomic DNA groups level by 
ARDRA, the remaining 4 isolates were identified to genus level, but died on 
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subculture. Duplicated isolates of the same Acinetobacter genomic DNA group 
were excluded from the same bacteremic episode which was defined as isolation 
of the same Acinetobacter species in one or more blood cultures of the same 
patient within a week. A total of 93 Acinetobacter isolates from 80 individual 
patients were thus analyzed, in which 7 patients had 2 bacteremic episodes and 3 
patients had 3 bacteremic episodes. No outbreak of Acinetobacter infection, was 
reported in the hospital during this period. 
Table 3.5 shows the distribution of Acinetobacter genomic DNA group in blood 
cultures. No significant difference was observed in comparing the distribution of 
genomic DNA group from ICU and Non-ICU (Mann-Whitney test, P > 0.05). A. 
baumannii, genomic DNA group 3 and 13TU accounted for over 75% (70/93) of 
the total isolates. Genomic DNA group 3 was the most common genomic DNA 
group, accounting for 39.8% (37/93). No isolate representing A. calcoaceticus 
(genomic DNA group 1) was found. Only 8 isolates (8.6%) of four other genomic 
DNA groups were found. The remaining 15 isolates (16.1%) were unclassified by 
ARDRA with 13 ARDRA patterns. 
Table 3.5 Distribution of different Acinetobacter genomic DNA groups in blood 
cultures. 
Number of isolates belonging to genomic DNA groups 
Acb complex AUA* 
Unit 2 3 13TU 5/17 8/9 10 17 U2 U9 U' Total (%) 
ICU 7 19 7 2 6 41 (44.1) 
Non-ICU 11 18 8 1 1 1 3 2 2 5 52 (55.9) 
Total 18 37 15 1 1 3 3 2 2 11 93 
(%) (19.4)(39.8)(16.1) (1.1) (1.1) (3.2) (3.2) (2.2) (2.2) (11.8) (100.0) 
AUA*: ARDRA unclassified acinetobacters, the ARDRA patterns of AUA referred to appendix 4. 
U' included 11 unclassifiable ARDRA patterns with only one isolate. 
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3.1.5 Isolation of acinetobacters from human carriage sites 
The study was carried out from July 1997 to October 1997. Two groups of 
individuals representing patients and community volunteers were sampled (see 
section 2.2.3). Altogether 1,060 carriage sites were sampled from 212 individuals. 
Table 3.6 shows the sample information including sampling periods, sex 
distribution, number of sample sites and the positive rates of the two study groups. 
The average number of positive sites per patient and community volunteers was 
0.62 and 0.53, respectively. During this study period, no outbreak of infection 
caused by Acinetohacter species was observed in the wards. 
Table 3.6 Sample information and acinetobacters positive rate of skin carriage 
study 
Total Number 
Female Male Carriage With at least one 
Subject Duration sites positive site for 
acmetobacters(%) 
Patients: 
Acute Ju ly -Sep t 1997 21 21 210 20(47.6) 
Chronic A u g - N o v 1997 22 15 185 29 (78.4) 
Community: 
Nurse (class 42) Oct 1997 34 4 190 25 (65.8) 
Medical students Oct 1997 50 45 475 46 (48.4) 
Total 127 85 1060 120 (56.6) 
Sex 
In the acute patient group, female patients (14 of 21) were significantly more 
likely to be positive carriers than male patients (6 of 21) (Chi Square test, P = 
0.031), whereas in the chronic patient and community volunteer groups, no 
significant difference between the sexes was found (Chi Square test, P > 0.05). 
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Patients and Volunteers 
There was no significant difference in the number of carriers positive at any site 
(Chi Square test,尸=0.19) or in the distribution of genomic DNA groups obtained 
from medical students and the student nurses (N42) (Mann-Whitney test, P = 
0.0523). There was a significant difference between the carriage rates of the two 
patient groups (Acute group: 20/42 versus chronic group: 29/37; Chi Square test, 
P = 0.009; OR，3.99; 95% confidence limit, 1.34 to 12.17). The carriage rate of 
the community volunteers, medical students and student nurses (N42), was not 
significantly different from that of acute patients (71/133 vs 20/42, Chi Square 
test, P = 0.5), but was significantly different from that of chronic patients (71/133 
vs 29/37, Chi Square test, P 二 0.006; OR, 032; 95% confidence limit, 0.12 to 
0.79). From the patient groups, 50% of the plates showed a light growth (1-100 
CFU/plate) and 43% showed a heavy growth (>1,000 CFU/plate), whereas, from 
the healthy volunteers, 79% showed a light growth, but 8% showed a heavy 
growth, (heavy growth: P < 0.0001; OR, 8.44; 95% confidence limits, 3.85 to 
18.79; light growth: ？ < 0.0001; OR, 3.74; 95% confidence limits, 2.01 to 7.00, 
Chi Square test). 
Distribution of Acinetobacter genomic DNA groups in carriage sites 
Table 3.7 shows 149 isolates (63.4%) belonged to Acb complex. Of these, 
genomic DNA group 3 accounted for 28.5% (67/235), 13TU and 2 accounted for 
21.3% (50/235) and 12.3% (29/235), respectively. Three isolates (2 in acute 
patients and 1 in a nurse) of genomic DNA group 1 (A. calcoaceticus) were 
isolated in the carriage study but not in clinical specimens. Another 41 isolates 
(17.4%) fell into 9 other genomic DNA groups. AUA accounted for 19% (43/236) 
of all isolates and gave 31 unclassifiable patterns with no predominant patterns 
observed. Excluding Acb complex, genomic DNA group 15TU was the 

























































































































































































































































































































































3.1.6. Isolation of acinetobacters from environmental samples 
Table 3.8 shows the source and the number of environmental samples examined. 
Table 3.8 Isolates oiAcinetohacter spp. from vegetables and soil samples 
No. of samples 
Sample Examined Positive (%) No. of isolates 
Vegetables 41 21 (51.2) 45 
Soil 
Summer 30 15 (50) 20 
Winter 30 7 (23.3) 14 
Total 60 22 (36.7) 34 
Vegetables 
Vegetable samples were purchased on 41 occasions throughout 12 months. A total 
of 45 isolates of acinetobacters were cultured from 21 samples of six varieties of 
vegetables. The positive rate of vegetables was 51.2% (Table 3.8). Table 3.9 
shows the distribution of Acinetohacter genomic DNA groups in different types of 
vegetables examined in this study. Twenty-five (54%) isolates were classified by 
ARDRA into 6 known genomic DNA groups, 2, 3, 10/11, 16, 13BJ and 15BJ. 
Genomic DNA group 3 was most frequently found, accounting for 31% (15/45). 
A total of 20 isolates (46%) were unclassified by ARDRA. 
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Table 3.9 Distribution oiAcinetohacter genomic DNA groups in vegetables 
No. of samples No. of isolates belonging to genomic DNA group 
Vegetable Examined positive Average 2 3 10 13BJ 15BJ 16 AUA Total 
Count 
(CFU/g)  
Pakcho丨（白菜） 6 3 2 x 10' 3 2 3 8 
Purslane (莫菊 6 4 2 x l 0 ' 1 1 1 1 5 9 
Coriander (元西 8 2 2x 10^  2 2 4 
Spring onion (憩： 9 6 3 x 5 2 7 
Spinach (MM) 6 4 2 x 10' 1 1 2 6 10 
Choi sum (菜心） 2 2 3 x 10' 3 2 2 7 
Others* 4 0 
Total 41 21 1 15 1 3 1 4 20 45 
(2%) (33%) (2%) (7%) (2%) (9%) (44%) 
Others* included celery (斧菜)，sweet bean (甜豆) 
Soil 
Soil samples were obtained in triplicates from 10 sites with and without human 
habitation. Sampling was carried out in September 1998 and in January 1999 at 
the same location sites. The overall positive rate for soil was 36.7% (Table 3.8). 
The positive isolation rate in the summer was 50% and in the winter was 23 %, 
there is a significant difference in this two seasons (Chi Square test, P = 0.002). 
Table 3.10 shows the distribution of Acinetohacter genomic DNA groups in soil 
samples, with 22 isolates (65%) from both seasons classified into 10 known 
genomic DNA groups. Genomic DNA group 3 accounted for 30% of total isolates 
in the hot season but was not found during the winter at the same locations and 
they were mostly (5/6) found in urban areas. Genomic DNA groups 2 and 17 
accounted for 14.7 and 11.8 % respectively. A total of 12 (35.3 %) isolates were 
















































































































































































































































































Diagram 3.1 shows the distribution of different Acinetohacter genomic DNA 
groups in environmental samples. A significant difference was seen in comparing 
the distribution of genomic DNA groups from vegetable and soil (Mann-Whitney 
test, P 二 0.0031). Genomic DNA groups 2, 3, 10 and 15BJ were found both in 
vegetable and soil samples. A large proportion of isolates from the environmental 
sources was unclassified by ARDRA (42%). Genomic DNA group 3 was the 
dominant genomic DNA group (26%) in these two types of environmental 
samples. 
Diagram 3.1: Distribution of Acinetohacter genomic DNA groups in 
Environmental samples 
GDG1 
I AUA GDG 5/7 
T GDG13BJ 
I GDG isa 4% 
GDG 17 zZ / 3% 




3.2.1 Prevalence oiAcinetohacter species in clinical specimens 
In the past decades, the genus Acinetohacter has become an important 
opportunistic pathogen worldwide, associated with hospital outbreaks and 
nosocomial infections (Tankovic 1994, Crowe 1995, Bernards 1997，Dijkshoom 
1996, Riley 1996). Acinetohacter is of particular importance in Hong Kong, 
which has a hot, humid climate (Ng 1996, Siau 1996). Several studies on the 
epidemiological and clinical features of Acinetohacter infection have been 
published worldwide (Ng 1996, Gemer-Smidt 1994, Bergogne 1996, Retailliau 
1979, Siegman 1993，Tilley 1994, Seifert 1993, Chu 1999，Horrevorts 1995). 
However comprehensive data about the prevalence of Acinetohacter genomic 
DNA groups in clinical specimens in this region are lacking. Ng et al. (1996) 
reported in a retrospective study oi Acinetohacter bacteremia that isolation rates 
of Acinetohacter in blood cultures ranged from 0.24% to 0.68% from 1987 to 
1994, similar to the results obtained in this project, 0.33%. Another retrospective 
study conducted in Hong Kong from 1990 to 1994 (Siau 1996) reported 
Acinetohacter spp. accounted for 7.4% of all bacteria reported in the routine 
laboratory. They described that, in the general ward, the isolation rates of 
Acinetohacter spp. from wounds, the urinary and lower respiratory tract were 
32.8, 25.8 and 26% of the total acinetobacters isolated, respectively. But in the 
ICU, 75% of acinetobacters isolates were from lower respiratory tract specimens. 
In this project, the prevalence of Acinetohacter species by screening clinical 
specimens was found to be 2.4%, and the lower respiratory tract specimens had 
the highest isolation rate of 11.1%. The results were different from Siau's study 
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because their study was a retrospective survey and the isolation rates were based 
on all bacteria isolated, i.e. 7.4% of acinetobacters from all bacteria, but in this 
project the isolation rate was based on the types of specimens, i.e. 2.4% of 
acinetobacters from all clinical specimens. 
Wise et al. (1990) reported that intestinal carriage of acinetobacters was common 
in Spinal Cord Injuries Unit (SCIU) and acinetobacters were carried in large 
numbers in affected patients, resulting in a large reservoir for the potential 
dissemination of acinetobacters. Sakarta et al. (1989) studied an outbreak situation 
in a neonatal ICU and reported that colonization of acinetobacters in the digestive 
tract was 40% of the infants studied. Wise et al (1990) surmised that faecal 
colonization of acinetobacters was transient in patients during the occurrence of 
an outbreak. There was substantial contamination of acinetobacters in the 
environment as demonstrated in their study. In contrast, Acinetobacter species was 
not isolated from faecal specimens in this project, a finding consistent with that of 
French et al. (1980) who found no rectal carriage of acinetobacters in an outbreak 
situation. 
3.2.2 Distribution of Acinetobacter genomic DNA groups in clinical 
specimens 
About 20% of screening isolates did not survive well on NA slopes. Such a high 
loss undoubtedly affected the study on the distribution of genomic DNA groups in 
clinical specimens. Since the screening study, all isolates have been stocked in NA 
slopes at room temperature and also in Glycerol broth at -70°C. 
There are several studies reported in the literature on the distribution of 
Acinetobacter species in clinical specimens in Hong Kong (Siau 1996, Ng 1996, 
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Ling 1996), but the genus and species identification of isolates were based on 
phenotypic characteristics. Phenotypic identification is problematic and many 
genomic DNA groups cannot be unambiguously separated (Dijkshoom 1990). 
Siau et al. (1996) report that in Hong Kong, 80% isolates of acinetobacters 
belonged to A baumannii or genomic DNA group 13TU but the identification 
system used was based on the routine biochemical tests and temperature tolerance 
at 44�C. The high-temperature tolerant isolates were identified presumptively as 
A. haumannii or genomic DNA group 13TU, but this was found to be unreliable 
(Gemer-Smidt 1991). Nowadays, the use of DNA-DNA hybridization or the new 
molecular methods for species identification has been widely adopted (Bouvet 
1986, Nishimura 1987, Bouvet 1989, Tjernberg 1989, Vaneechoutte 1995). In this 
project, the modem identification method and nomenclature scheme has been 
applied to study clinical isolates in an endemic situation. 
There are three European studies reported in the literature on the distribution of 
Acinetobacter species in clinical specimens (Seifert 1993, Horrevorts 1995, 
Gennari 1993). Gennari et al (1993) reported that A. baumannii predominated in 
clinical specimens. Similar findings were reported by Seifert (1993) who found A. 
baumannii to be the most frequent (72%), followed by genomic DNA group 3 
(9.4%) and A. johnsonii (genomic DNA group 7) (3.6%). The unidentified species 
accounted for 2.8%. The results obtained in the present project differ from these 
studies. A. baumannii (31%) and genomic DNA group 3 (29%) were the most 
common DNA groups in clinical specimens, followed by genomic DNA group 
13TU (18%). Unclassifiable isolates (AUA) accounted for 18%. 
In order to study the clinical importance of different genomic DNA groups, we 
used blood culture isolates as a guide to their relative clinical significance. We 
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found that genomic DNA group 3 was the most common species in blood 
cultures, accounting for 40% of the total isolates, followed by A baumannii 
(19%) and genomic DNA group 13TU (16%). Although the clinical significance 
of the positive samples was not studied in this project, others have shown 
infection rates of 30 to 55% among patients with positive blood cultures (Dy 
1999, Gemer-Smidt 1987). Ng et al (1996) reported 72% of Acinetobacter 
isolated from blood cultures were of clinical significance. Genomic DNA group 3 
(76%) also predominated in clinical specimens in a 24-month prospective study of 
a neonatal ICU in the Netherlands (Horrevorts 1995), followed by A. baumannii 
(8%) and A. junii (3%) in a non-outbreak situation. The positive rate for 
Acinetobacter in neonatal ICU in our study was 1%. 
The differences in the distribution of genomic DNA groups between the present 
and other studies may be geographical, but another reason may be that isolates of 
genomic DNA group 3 were incorrectly identified as A. baumannii, as was the 
case with API 20NE in Horrevorts's study and was suggested by the authors 
themselves. This could have resulted in a general underestimation of the clinical 
significance of genomic DNA group 3. 
3.2.3 Distribution of different genomic DNA groups of Acinetobacter on 
carriage sites 
Over 30 years ago, Taplin et al. (1963) suggested that at least 25% of normal 
individuals carried glucolytic species of Acinetobacter (then named Herellea 
vaginicola) on their skin and 10% carried the non-glucolytic Acinetobacter 
species {Mima polymorpha). In more recent studies, Buxton et al. (1978), French 
et al, (1980), and Sakata et al. (1989) reported that the skin carriage of 
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Acinetohacter spp. on hands of hospital personnel was 33%, 29% and 9%, 
respectively, which included transient hand carriage rates. However we should be 
mindfiil of the different taxonomy used. 
To date, there have been two studies reported in the literature on skin and mucous 
membrane carriage of Acinetohacter based on a molecular classification scheme 
(Berlau 1999, Seifert 1997). Both were carried out on European subjects. Berlau 
et al (1999) described an overall positivity rate of 44% for Acinetohacter in 191 
healthy subjects in London. Seifert et al. (1997) in Cologne, Germany, found that 
30 of 40 patients (75%) and 17 of 40 healthy controls (43%) were positive at any 
sites. Similar to results in this project, 62% of patients and 53.4% of healthy 
subjects were positive. The extent of colonization with Acinetohacter spp. seemed 
to increase during the course of hospitalization as isolation rates for chronic 
patients was 78.4%, but 47.6% in acute patients. 
Skin carriage in the healthy subjects was significantly lighter than that in patients. 
This indicates that the carriage in the former could be the result of contamination, 
whereas in the latter, it could be the result of colonization. 
Seifert et al. (1997) found the most frequently isolated species on skin of 
volunteers were A. Iwoffii (genomic DNA group 8/9) (47%), A. johnsonii 
(genomic DNA group 7) (21%), A. radioresistens (12%) and genomic DNA group 
3 (11%). The clinically important species A. baumannii (genomic DNA group 2) 
and 13TU accounted for only 0.5 and 1%, respectively. Similar results were also 
obtained in London, UK. Berlau et al. (1999) found that A. Iwoffii (61%) was the 
most common species on skin of healthy volunteers, followed by genomic DNA 
group 15BJ (12.5%) and radioresistens (8%). Thus the natural habitats of the 
clinically important species remain unknown in Europe. 
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The results of this project were different from the European studies. Genomic 
DNA group 3 (35.2%) was the commonest species found on superficial carriage 
sites among healthy subjects, followed by genomic DNA group 13TU (15.2%) 
and 17 (8%). The commonest species in European studies, A. Iwoffii, only 
contributed to 1.6% on healthy subjects in this study. For carriage sites of 
hospitalized patients, genomic DNA group 13TU (28.2%) was the commonest 
species, followed by genomic DNA group 2 (21.8%) and 3 (20.9%). It may be 
that locality accounted for the difference in skin carriage of Acientoabcter species. 
We demonstrated the high prevalence of Acb complex on human skin in this 
region. Skin carriage may play an important role in the contamination of hospital 
environments and the hands of hospital staff during contacts, thereby contributing 
to the spread and persistence of superficial carriage, colonization or infections. 
3.2.4 Distribution of different genomic DNA groups of Acinetohacter in 
environmental samples 
The ubiquity of the genus Acientoabcter is well described and these bacteria have 
been isolated from different environmental sources, such as soil, vegetables, 
water, sewage, raw milk and cheese (Gennari 1993, Gennari 1992, Khan 1992, 
Khan 1996，Baumann 1968). There are very few reports in which Acinetohacter 
isolates from environmental sources have been grouped according to the latest 
taxonomic scheme. In the studies from an Italian group, Gennari et al，assigned 
acinetobacters previously isolated from various foods to the old biotype Iwoffii 
(Gennari 1984, Gennari 1985, Gennari 1986). They investigated 170 
acinetobacters isolated from fresh and spoiled meat and fish, vegetables, raw milk 
and cheese purchased from supermarkets in Italy. The commonest species was A. 
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johnsonii (genomic DNA group 7), followed by A. Iwoffii (genomic DNA group 
8/9), genomic DNA groups 15 and 11. A recent study in London reported 17% of 
vegetables purchased from local supermarkets yielded Acinetobacter with A. 
baumannii and genomic DNA group 11 being the most common, each with a 
frequency of 27% (Berlau 1999). There was a difference between United 
Kingdom and Italy in the distribution of Acinetobacter species in the 
environmental samples (Gennari 1986，Berlau 1999). In this project, genomic 
DNA group 3 was the most frequent species (26.6%), followed by A. baumannii 
(7.6%), genomic DNA group 16 and 17 each with a frequency of 5.1%. 
Although it is not as common for the Chinese to consume fresh salad vegetables 
as Western people do, we may use some uncooked vegetables, such as coriander 
and spring onion, as toppings. Two (25%) isolates of acinetobacters were isolated 
from 8 samples of coriander and 6 (66.7%) isolates from 9 samples of spring 
onion. Raw food may serve as vehicles of transmission to homes and hospitals. 
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CHAPTER 4 AN ASSESSMENT OF tDNA FINGERPRINTING 
IN THE IDENTIFICATION OF ACINETOBACTER SPECIES 
In this study, the usefulness of the tDNA fingerprinting as a tool in identifying 
Acinetohacter species was investigated. tDNA fingerprinting uses primers 
designed to amplify the spacer regions of tDNA clusters. Amplification profiles 
are likely to differ at the species level and would thus be a measure of genetic 
relatedness. Using fluorescein-labelled primers, the amplification products were 
electrophoresed in an automated DNA sequencer. 
4.1 Results 
4.1.1 Complexity of tDNA fingerprint patterns 
Within the size range between 50 and 821 bp, the number of bands generated 
varied from 12 to 20. Fragments between 114 and 500 bp had the best 
discrimination for the 34 reference Acinetohacter strains, thus only fragments 
within these sizes were included for cluster analysis. 
4.1.2 Assessment of tDNA fingerprinting 
An intragel and intergel comparison of tDNA fingerprints of internal reference 
strain, A. baumannii (NCTC 12156), was set up for the assessment of tDNA 
fingerprinting. It was loaded in two or more tracks on each gel. 
Analysis of intragel comparison 
Five different tDNA samples of the internal reference strain generated from the 
same PGR run were loaded into five lanes of the same gel. The band patterns of 
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Fig 4.1: Cluster analysis of tDNA fingerprints of the internal reference strain, Acinetobacter 
baumannii NCTC 12156, obtained from five samples generated from the same PCR run loaded 
onto the same gel. The scale displays the Pearson product-moment correlation coefficient in 
percentage shown above the dendrogram. 
Analysis of the intergel comparison of internal reference strain 
A sample of the internal reference strain was loaded once onto 13 different gels 
for analysis. The similarity was found to be approximately 87% (Fig 4.2). 
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Fig 4.2: Cluster analysis (UPGMA) of tDNA fingerprints of the internal reference strain, 
Acinetobacter baumannii NCTC 12156 obtained from the same PCR sample loaded onto 13 
different gels. The scale displays the Pearson product-moment correlation coefficient in percentage 
shown above the dendrogram. 
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Analysis of the intergel comparison of Reference Acinetobacter strains 
Acinetobacter genomic DNA groups 2, 5, 8/9, 10, 12, 13TU and 16 each 
containing two reference strains were used for the intergel comparison study. 
Samples of these 14 strains were prepared in duplicate in two PCR runs and 
loaded into two separate gels. The band patterns were analyzed for their 
correlation levels (Fig 4.3). The highest correlation level, 96.7%, was found in 
genomic DNA group 10 and the lowest, 72%, in genomic DNA group 12. 
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Fig 4.3: Cluster analysis of tDNA fingerprints of 7 DNA groups each containing 2 reference 
strains in duplicates obtained from two separate gels. The scale displays the Pearson product-
moment correlation coefficient in percentage shown above the dendrogram. 
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4.1.3 Construction of fingerprint database with the Reference Acinetohacter 
strains 
A fingerprint database was constructed from the combination of tDNA 
fingerprints of the 34 reference Acinetohacter strains representing 18 DNA 
groups. With the exception of DNA groups 6 and 11, all the other genomic DNA 
groups were represented by two strains. The dendrogram is shown in Fig 4.4. 
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Fig 4.4: tDNA fingerprints of a fingerprint database of Acinetohacter reference strains. The scale 
displays the Pearson product-moment correlation coefficient in p^centage shown above the 
dendrogram. 
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4.1.4 Delineation of different genomic DNA groups in the fingerprint 
database 
At a similarity level of 80% (Fig 4.4), 14 clusters were distinguished in the 
dendrogram. Clusters containing only one DNA group included groups 5 (97.2%), 
4 (98.8%), 8/9 (94%), 15TU (91.1%), 12 (89.8%), 3 (98.8%) and 10 (99.9%). 
Genomic DNA groups 6 and 11, each containing only one reference strain could 
also be distinguished. However, DNA groups 1, 2, 3 and 13TU of the Acb 
complex and genomic DNA groups 7’ 13BJ, 14BJ, MTU, 15BJ, 16 and 17 could 
not be distinguished at the 80% cut-off level. Genomic DNA group 1 was 
clustered distant firom other members of Acb complex. 
4.1.5 Cluster analysis of tDNA fingerprints of Acinetobacter isolates 
classified by ARDRA 
Bacterial strains 
Bacterial strains were randomly chosen from clinical specimens of individual 
patients, carriage site of individual subjects and different environmental samples. 
A total of 136 of 500 isolates belonging to 16 Acinetobacter DNA groups were 
studied. All isolates had been identified by ARDRA. The origin of the isolates is 
shown in Table 4.1. 
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Table 4.1: Origin of the isolates oi Acinetobacter species 
No of isolates  
DNA groups Carriage site Clinical Environmental Total 
- - 2 5 
2 4 12 6 22 
3 3 8 13 24 
13TU 9 13 22 
5 1 1 
7 8 4 12 
8/9 5 2 7 
10 3 3 6 
11 2 2 
12 6 2 8 
16 2 2 4 
17 13 3 16 
13BJ/14TU 1 1 
14BJ 1 1 
15BJ 1 1 2 
15TU 3 3 
Total 95 n ^ 136 
Fingerprint analysis 
tDNA fingerprints of 136 Acinetobacter isolates were matched with the database 
constructed from tDNA fingerprints of the reference strains. There were 26 
clusters, coded A to Z, in the dendrogram (Fig 4.5). The tDNA fingerprinting 
patterns of DNA groups 8/9, 12 and 10 (clusters P, U and Z), represented by 19 
isolates, matched with the corresponding reference DNA groups. All 68 isolates 
of DNA groups 2, 3 and 13TU fell into five distinct clusters I, J, K, L and M. 
Genomic DNA group 1 was divided into 6 clusters I, K, N, O, S and T. Other 
DNA groups did not correlate with the tDNA patterns of the corresponding 
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Fig 4.5: Dendrogram constructed by UPGMA cluster analysis of tDNA fingerprints from 136 
Acinetohacter isolates with 34 reference Acinetohacter species. Vertex triangle indicates average 
similarity value of the cluster. The scale displays the Pearson product-moment correlation 
coefficient in percentage shown above the dendrogram. 
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4.2 Discussion 
Direct amplification of intervening sequences in the tRNA coding sequence 
(tDNA fingerprinting) provides a discriminatory amplification profile that does 
not require any further processing of the PGR products. This method has already 
been evaluated for the identification of Acinetohacter species at the DNA group 
level, but the isolates were mainly from environmental sources (Wiedmann 1994). 
Evaluation of the tDNA fingerprinting method against a large panel of isolates 
identified by DNA-DNA hybridization was performed by a German group 
(Ehrenstein 1996). In this project, the procedure used was similar to that in the 
German study, but acinetobacters from clinical, carriage sites and environmental 
sources were included for investigation. 
The results of intragel and intergel comparison of the internal reference strain 
were not satisfactory, the similarity was found to be 86.3% and 87%, respectively. 
The lack of standardization of the DNA template concentration and PGR reagents 
could have contributed to the discrepancies. 
Fingerprint analysis demonstrated that genomic DNA groups (1, 2, 3 and 13TU) 
of the Acb complex could not be clearly distinguished by tDNA fingerprinting. 
The lack of discrimination within Acb complex species may be explained by the 
high degree of overall sequence homology. Even by DNA-DNA hybridization, 
these groups were distinguished at a similarity level of 70%, the cut-off value for 
the definition of separate DNA groups (Tjemberg 1989). In this study, genomic 
DNA groups 2, 3，and 13TU were grouped together in five distinct clusters. 
Isolates of genomic DNA group 1 were grouped into six clusters, two of which 
(cluster S and T) were in genomic DNA groups other than the Acb complex. 
The discrimination among DNA groups 8/9, 10, 11 and 12 was clear-cut, a similar 
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finding as in the German study (Ehrenstein 1996). Isolates belonging to other 
DNA groups were not successfully distinguished, and this may be that the number 
of isolates used was too limited. 
The results of this study demonstrate that tDNA fingerprinting distinguishes 
satisfactorily between some genomic DNA groups of Acinetohacter but does not 
discriminate within the Acb complex. Moreover, the degree of similarity 
expressed in the dendrogram cannot be considered as absolute, since subtle 
variations in the fluorescence data can contribute to changes in the dendrogram. 
One should also be mindful that only 1-2 reference strains were available for each 
genomic DNA groups to construct the database. 
However, tDNA fingerprinting is less technically demanding and a less time 
consuming method than ARDRA or DNA-DNA hybridization. It could therefore 
be used as a screening method for a large number of isolates e.g. to screen for the 
Acb complex. 
4.3 Conclusion 
In general, tDNA fingerprinting technique is superior in its simplicity and speed 
compared with DNA-DNA hybridization or ARDRA. Also，the analysis can be 
performed with an automated fragment detection system. However, the results of 
cluster analysis of reference Acinetohacter strains demonstrated it had low 
discrimination of the 19 genomic DNA groups. The cluster analysis of 136 wild 
strains showed overlapping in the linkage level of some genomic DNA groups. In 
order to improve the reproducibility of tDNA fingerprints, standardization of 
template concentration and reagents are necessary. Nevertheless, tDNA 
fingerprinting could be a method of choice, should screening for members of the 
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Acb complex be necessary for a large number of isolates, for example, in an 
outbreak situation. 
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CHAPTER 5 BIOTYPING OF ISOLATES FROM CLINICAL 
SPECIMENS, CARRIAGE SITES AND ENVIRONMENTAL 
SAMPLES 
5.1 Results 
A total of 20 isolates of A. baumannii, 97 genomic DNA group 3 and 22 genomic 
DNA group 13TU from clinical specimens, human carriage sites and 
environmental samples were randomly selected for biotyping. The biotyping 
scheme (section 2.5) was based on the utilization of levulinate, citraconate, L-
phenylalanine, 4-hydroxybenzoate and L-tartrate. All isolates were successfiilly 
biotyped and seven biotypes, 1, 2, 8, 9, 10, 11 and 18 were determined. 
5.1.1 Biotypes of A baumannii 
Three biotypes, 8, 9 and 10, of A. baumannii were determined (Table 5.1), of 
which bio type 9 was the most frequent with 75% (15/20), followed by bio type 8 
(15%) and 10 (10%). Biotypes 9 contains 71% (10/14) of clinical isolates. 
Table 5.1 Biotypes of baumannii 
Number of isolates of biotype 
Source Specimen 8 9 10 
Clinical Respiratory tract 2 
Eye swab 1 
Urine 2 
Body fluid 1 
Wound swab 6 1 
Tissue 1 
Carriage site Healthy subject 1 3 
Environmental Soil 2 
Total 3 15 2 
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5.1.2 Biotypes of genomic DNA group 3 
Six biotypes, 1，2，8, 9, 11 and 18，were determined (Table 5.2). Biotype 9 was the 
most common, which accounted for 64.9% (63/97) of all isolates examined, 
followed by biotype 8 with 26.8% (26/97). Other biotypes gave frequencies of 
less than 3%. Among 38 isolates from clinical specimens, 87% (33/38) of isolates 
were represented by biotype 9 and this biotype predominated among carriage site 
isolates, 57% (24/42). Unlike isolates from clinical and carriage sites, the most 
frequent biotype in environmental samples was biotype 8 which accounted for 
53% (9/17). 
Table 5.2 Biotypes of genomic DNA group 3 
Number of isolates of biotype 
Source Specimen 1 2 8 9 11 
Clinical Blood culture 1 19 
Respiratory tract 2 7 
Urine 1 4 
Wound swab 1 1 
Body fluid 2 
Carriage site Patient subject 4 11 1 
Healthy subject 1 9 13 1 2 
Environmental Soil 1 2 3 
Vegetable 1 7 3 
Total 2 1 26 63 2 3 
5.1.3 Biotypes of genomic DNA group 13TU 
Because no genomic DNA group 13TU was isolated from environmental samples, 
only isolates from clinical and carriage specimens were used for biotyping. Three 
biotypes, 8，9 and 10, were found. Of the 22 selected isolates of genomic DNA 
group 13TU, 80% (18/22) were represented by biotype 9. 
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Table 5.3 Biotypes of genomic DNA group 13TU 
Number of isolates ofbiotype 
Source Specimens 8 9 10 
Clinical Blood culture 1 
Respiratory tract 2 1 
Urine 1 
Wound swab 1 1 
Carriage site Healthy subject 1 13 1 
Total 1 18 3 
5.2 Discussion 
Before the introduction of genotypic typing methods, such as pulsed-fleld gel 
electrophoresis (PFGE), phenotypic typing methods, such as biotyping, were used 
for the allocation of isolates according to biotyping classification schemes 
(Bouvet 1987, Bouvet 1990). Biotyping is a simple method, so it was used in this 
project to correlate the predominant genomic DNA groups isolated from clinical 
and environmental sources. 
Biotyping comprised five tests to identify 19 biotypes of A. calcoaceticus - A. 
baumannii complex {Acb complex) (Bouvet 1987, Bouvet 1990). The biotyping 
system was well developed for A. baumannii because it is the most prevalent 
species in clinical specimens in Europe (Bouvet 1987，Bouvet 1990, Dijkshoorn 
1996). The distribution of Acinetohacter species differed in clinical and 
environmental samples. Genomic DNA groups 3 and 2 were predominant in 
clinical sources, genomic DNA group 3 and 13TU in carriage sites, genomic DNA 
group 3 and 2 in environmental sources. 
In this project, 139 isolates of genomic DNA groups 2, 3 and 13TU were 
randomly selected for biotyping. Bio type 9 of A. baumannii dominated in clinical, 
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carriage and environmental sources. Mulin et al. (1995) reported that biotype 9 of 
A, baumannii was one of the prevalent biotypes in a French hospital. However, 
Gemer-Smidt et al (1993) pointed out that the majority of isolates identified 
phenotypically to A. baumannii biotype 9 actually belonged to genomic DNA 
group 13TU, and the relatively high reported incidence of this species and the 
biotype in outbreaks could have in fact been caused by genomic DNA group 
13TU. 
For genomic DNA group 3, the representative biotype was biotype 9 in clinical 
and carriage sources and biotype 8 in enviromnental sources. However, biotypes 8 
and 9 differ only in one carbohydrate utilization, tartrate. This difference may 
reflect true metabolic differences in different environments or lack of 
reproducibility of the test. 
As discussed in section 3.2.4, genomic DNA group 13TU appeared to have a 
restricted habitat of human skin and the respiratory tract. For 13TU, biotype 9 was 
the commonest in clinical and carriage specimens. 
In conclusion, biotyping based on five carbohydrates is not discriminative enough 
for clonal differentiation of isolates necessary for the investigation of outbreaks. 
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CHAPTER 6 ANTIMICROBIAL SUSCEPTIBILITIES OF 
ACINETOBACTER SPECIES 
Details of procedure of determination of minimum inhibitory concentrations 
(MCs) are described in section 2.7. 
6.1 Results 
6.1.1 Bacterial strains 
The in vitro activities of 11 antimicrobial agents against 417 Acinetobacter strains 
isolated from clinical, environmental sources, and carriage sites were studied. Of 
( 
these strains, 74 were identified as A. haumannii (genomic DNA group 2)，109 as 
genomic DNA group 3, 73 as genomic DNA group 13TU, 68 were assigned to 
other genomic DNA groups and 93 could not be grouped by ARDRA (AUA). The 
origins of strains are shown in Table 6.1. 
Table 6.1 Origins of Acinetobacter isolates 
No. of isolates  
Genomic DNA group Clinical Carriage site Environmental Total 
1 (A. calcoaceticus) 3 1 4 
2 {A. baumannii) 44 27 3 74 
3 56 35 18 109 
10 3 1 1 5 
12 (A. radioresistens) 4 4 
16 1 2 3 6 
17 7 15 4 26 
13TU 32 41 73 
15BJ 6 1 7 
15TU 8 8 
8/9 {A. Iwoffii) 1 2 3 
AUA 35 33 25 93 
Others* 2 3 5 
Total \19 179 59 417 
•Others included genomic DNA group 5/7，11, 13BJ, 14BJ. 
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6.1.2 Susceptibilities oiAcinetobacter genomic DNA groups 
The M C at which 50% of the isolates are inhibited (MIC50), The MIC at which 
90% of the isolates are inhibited (MIC90) and the percentage of resistance of 
Acinetobacter genomic DNA groups to 11 antimicrobial agents are shown in 
Table 6.2. Any genomic DNA groups with less than or equal to five isolates will 
not be further discussed in this section. 
Acb complex 
Because the number of isolates of A. calcoaceticus was too small, it was not 
included in the discussion here. Acb complex was more resistant than other 
genomic DNA groups. A. baumannii was the most resistant genomic DNA group, 
4.1% to 59.4% showing resistance to nine antimicrobial agents. They had high 
frequencies of resistance to extended spectrum cephalosporins, i.e. 4.1% to 
cefepime and 35.1% to ceftazidime. In addition, A. baumannii was significantly 
more resistant to sulbactam than genomic DNA group 3 (P < 0.001, 11/63 versus 
0/109) and 13TU (P 二 0.0002, 11/63 versus 1/73). Imipenem and netilmicin were 
shown to have excellent activity against A. baumannii. 
Genomic DNA group 3 showed resistance to 10 antimicrobial agents ranging 
from 0,9 to 60.6%. Only one isolate from blood culture was resistant to imipenem 
with a MIC of 16 ^ig/ml and one isolate was resistant to both netilmicin and 
levofloxacin. 
With the exception of A. baumannii, sulbactam, cefepime, amikacin, netilmicin, 
gentamicin, ciprofloxacin, levofloxacin and imipenem, exhibited good activities 
against genomic DNA groups 3 and 13TU. 
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ARDRA unclassified acinetobacters (AUA) 
AUA showed resistance to ampicillin (54.8%), ceftazidime (35.4%) and 
sulbactam (15.1%). Fluoroquinolones were the most active agents against AUA, 
and only one of 93 isolates exhibited resistance to both ciprofloxacin and 
levofloxacin. 
Antimicrobial agents 
For P-lactam antimicrobial agents, cefepime was more active than ceftazidime, 
with the overall frequencies of resistance as 5.1% (25/492) and 25% (124/492) 
respectively. Among the three aminoglycosides tested, netilmicin was the most 
active against Acinetohacter species. Only one strain of genomic DNA group 3 
isolated from blood culture was resistant to netilmicin with MIC of 32 fig/ml. 
Amikacin and gentamicin exhibited good activity against genomic DNA groups 3 
and 13TU. The two fluoroquinolones tested were very active against 







































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.1.3 Distribution of resistance patterns in Acinetohacter species 
Table 6.3 compares the resistance patterns of A. baumannii, genomic DNA group 
3, 13TU and AUA isolated from clinical, carriage sites and environmental 
samples. The proportions of isolates showing resistance to four or more agents 
(multidrug resistance) in these four genomic DNA groups were statistically 
different (Chi Square test, P < 0.001). A. baumannii had the highest frequency in 
resistance to four or more agents, accounting for 28.4% (21/74), followed by 
AUA and genomic DNA group 3 with frequencies of 13.9% and 11.9% 
respectively. Thus multidrug resistance was common among A. baumannii. 
Genomic DNA group 13TU was the least resistant. 
For A. baumannii, the proportion of multidrug resistance of isolates from clinical 
sources was significantly higher than those from skin and environmental sources 
(20/44 versus 1/30, Chi Square test, P < 0.001; OR, 24.17; 95% confidence limits, 
3.02 to 518.4). For genomic DNA group 3, the proportion of clinical isolates 
resistant to at least four antimicrobials was significantly greater than that of non-
clinical isolates (13/56 versus 0/53, Chi Square test, P < 0.001). For AUA, similar 
results were observed, clinical isolates were significantly more likely to be 
multidrug resistant than carriage sites and environmental isolates (12/35 versus 
0/41, Chi Square test, P < 0.001). For genomic DNA group 13TU, the resistance 
patterns of isolates from clinical and skin carriage was not statistically different 
(2/32 versus 0/41, Chi Square test, P = 0.104). No isolate from skin carriage or 
environmental sources showed resistance to three or more antimicrobial agents in 
genomic DNA group 3 and 13TU. Four clinical isolates of A. baumannii showed 













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































6.2.1 Antimicrobial susceptibilities of different genomic DNA groups of 
Acinetobacter from different sources 
The changing spectrum of nosocomial pathogens and the widespread emergence 
of antimicrobial resistance have made national and international surveillance an 
important means to monitor the prevalence of resistance. Such information can aid 
the prudent use of antimicrobial agents. Surveillance reports, however, often did 
not use the modem taxonomic scheme for Acinetobacter isolates (Courcol 1989, 
Ruiz 1999). Until recently, the genus Acinetobacter contained the single species 
Acinetobacter calcoaceticus which was subdivided into the two subspecies or 
biovars A. calcoaceticus subsp. anitratus and A. calcoaceticus subsp. Iwoffii. A. 
calcoaceticus subsp. anitratus was frequently reported to be much more resistant 
to antibiotics than A. calcoaceticus subsp. Iwoffii (Bergogne 1986, Bergogne 
1987). In 1986, the taxonomy of the genus Acinetobacter was revised by Bouvet 
and Griniont. Most strains of A. anitratus were classified as A. baumannii, 
genomic DNA groups 3 and 10, whereas most strains of A. Iwoffii were classified 
as A junii, A. Iwoffii, and genomic DNA group 11. Most studies reporting 
antimicrobial susceptibilities of Acinetobacter spp. were not based on this new 
taxonomy (Bergogne 1986, Joly-Guillou 1986, Vallee 1990). The composition of 
genomic DNA groups may thus vary from center to center and the susceptibility 
patterns of acinetobacters reported may therefore not be truly comparable. 
In this project, in vitro activities of 11 antimicrobial agents against 382 ARDRA-
classified acinetobacters and 110 ARDRA unclassifiable isolates (AUA) were 
studied. A. baumannii isolates were significantly more resistant than those 
belonging to other genomic DNA groups. This is consistent with three recently 
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published reports (Freney 1989, Traub 1989, Seifert 1993). Seifert et al. (1993) 
reported that only 8% and 42.5% of A. baumannii isolates were fully susceptible 
to ampicillin and amikacin, respectively, and 30% and 37% of the isolates were 
intermediate or resistant to ceftazidime and ciprofloxacin, respectively. Similar 
results were seen in this project, 59.4% and 35.1% of all A. baumannii isolates 
were resistant to ampicillin and ceftazidime, respectively and 27% were resistant 
to ciprofloxacin. 
6.2.2 Emergence of P-Lactam resistance 
As with other Gram-negative organisms, most resistance to p-lactams in 
Acinetobacter species is associated with the production of p-lactamases, including 
the widely distributed TEM-1, TEM-2 and CARB-5 enzymes (Devaud 1982, 
Goldstein 1983, Joly-Guillou 1988). However, the presence of these enzymes 
does not explain all p-lactam resistance in Acinetobacter. Other enzymes which 
are chromosomally encoded cephalosporinases, e.g Ambler class C enzyme, is 
also responsible for cephalosporin resistance in Acinetobacter species. We 
demonstrated in this study that with the exception of A. calcoaceticus, A. Iwoffii 
and genomic DNA group 12, most of the Acinetobacter genomic DNA groups 
showed resistance to ampicillin, ranging from 12.5 to 100%. We found 54% of 
clinical isolates (24/44) of A. baumannii and 51.7% genomic DNA group 3 
(29/56) resistant to ceftazidime. Cefepime showed good activity against 
acinetobacters when compared with ceftazidime. No isolate of genomic DNA 
group 3 and 13TU from skin carriage and environmental sources was resistant to 
cefepime. 
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6.2.3 Activity of Sulbactam 
The in vitro intrinsic activity of sulbactam against Acinetohacter species has been 
described (Traub 1989, Retsema 1986). Sulbactam competitively binds with 
penicillin-binding proteins (PBPs) la and 3 (Kazmierczak 1989, Urban 1993) 
which represent lethal targets within the bacteria. In this study, we found that 
sulbactam had good activity, the resistance rate ranged from 0 to 16.2%, against 
Acinetohacter species. The frequency of resistance to sulbactam was less than that 
of ceftazidime. 
6.2.4 Susceptibility of Carbapenem 
Carbapenem resistance has been emerging and causing significant problems for 
treatment (Riley 1996, Tankovic 1994). Most carbapenem-resistant acinetobacters 
have OXA-type-P-lactamases with weak activity against carbapenems; such 
enzymes have been found in Argentina, Belgium, France, Kuwait, Scotland, Spain 
and Singapore (Afeal-Saha 1998, Afzal-Saha 1999). Other resistances mediated 
by metallo-p-lactamases have been reported in acinetobacters from Cuba, Italy 
and Japan (Comaglia 1999, Perez 1996, Takahashi 2000). The enzyme from 
Italian isolates, designated IMP-2, has 84,9% amino acid homology with IMP-1, a 
metallo-(3-lactamases that is widespread in Pseudomonas aeruginosa, Serratia 
marcescens and acinetobacters in Japan (Osan 1994, Senda 1996, Senda 1996b). 
Recently a novel metello-P-lactamases against imipenem, IMP-4, has been 
reported in Hong Kong (Chu 2001). In this study, imipenem showed excellent 
activity against Acinetohacter species and only one resistant isolate of genomic 
DNA group 3 from blood culture with MIC of 16 |j.g/inl was found. Thus 
imipenem remains effective against mult ire sistant Acinetohacter spp. 
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6.2.5 Quinolones resistance 
Less than 2% of Acinetobacter species showed resistance to the two 
fluoroquinolones tested in this study. Resistance to fluoroquinolones in A. 
baumannii was significantly higher than other species (Chi Square test, P < 
0.005). Similar to Ling's study (1996), 13 % of acinetobacters isolates from blood 
cultures were resistant to ciprofloxacin while 5% were resistant to ofloxacin. The 
resistance in^ . baumannii was mainly mediated through mutation(s) oi gyrA and 
parC genes. A reduction of accumulation of quinolones, either by a decrease in 
the permeability of the outer membrane or an increased efflux from the cell, may 
also be involved. The resistance mechanism of other genomic DNA groups may 
be the same as A. baumannii. 
6.2.6 Aminoglycoside resistance 
Aminoglycosides are useful for treatment of infection caused by Acinetobacter 
species since they are bactericidal and display synergy when combined with p-
lactams. All three types of aminoglycoside-modifymg enzymes, acetylating, 
adenylating and phosphorylating, have been identified within clinical 
Acinetobacter strains, but geographic variation in the incidence of particular genes 
has been observed (Shaw 1991，Shaw 1993). Some strains have been found to 
contain more than one aminoglycoside resistance gene, with as many as six 
different resistance genes being identified in some isolates. 
Of the 195 Acinetobacter isolates, Soussy et al. (1993) reported that 71% was 
resistant to amikacin and 73% to netilmicin. In another study of 322 
Acinetobacter isolates from a French ICU (Miller 1994), amikacin resistance was 
66%, netilmicin 60% and gentamicin 74.5%. These rates of resistance to 
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aminoglycosides are much higher than our results here. We found that the overall 
frequencies of resistance in all genomic DNA groups from all sources were 6.7% 
to gentamicin, 4.3% amikacin and 0.2% netilmicin. Only one isolate of genomic 
DNA group 3 from blood cultures was resistant to netilmicin with MIC of 32 
Igf ih Enger al. (1996) found only 1% of blood culture isolates resistant to 
amikacin. 
6.3 Conclusion 
There were significant differences in antimicrobial susceptibilities of the same 
genomic groups obtained from different sources, e.g. differences between clinical 
and non-clinical isolates of genomic DNA group 3, and of different genomic 
groups obtained from the same source, e.g. A. baumannii more resistant than that 
of other genomic DNA groups from clinical source. Our results highlight the 
importance of delineation of genomic groups Acinetohacter when comparing 
susceptibility data from different studies. Of all genomic DNA groups examined, 
A. baumannii was the most resistant. High resistance rates of A. baumannii to 
generation cephalosporins (35% to ceftazidime) and fluroquinolones (27% to 
ciprofloxacin and 13.5% to levofloxacin) were demonstrated. Aminoglycosides, 
sulbactam and imipenem were active against Acinetohacter especially for those 
other than A. baumannii. 
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CHAPTER 7 GENERAL DISCUSSION 
7.1 Significance of delineation of genomic DNA groups of Acinetohacter 
Acinetohacter species are ubiquitous non-fermentative organisms that are 
distributed widely in nature. In early decades of microbiology, organisms regarded 
today as members of the genus Acinetohacter were described under different 
genus and species names. In the Bergey's Manual of Systemic Bacteriology 
(1984), all strains of Acinetohacter were considered to be a single species named 
A. calcoaceticus. 
Recently, the taxonomy of the genus Acinetohacter has changed considerably. In 
1986, Bouvet and Grimont distinguished 12 different genomic DNA groups 
within the genus by the use of DNA-DNA hybridization (Bouvet 1986). Three 
genomic DNA groups numbered 2, 5, and 7 were given names, A. baumannii, A. 
junii and A. johnsonii, while the previously named A. calcoaceticus, A. 
haemolyticus and A. Iwoffii were allocated to genomic DNA groups 1，4，and 8, 
respectively. Another species, A. mdioresistens, was described in 1988 
(Nishimura 1988) and appeared later to correspond to DNA group 12 (Tjemberg 
1989). In 1989, Tjemberg and Ursing (Tjemberg 1989) presented five additional 
DNA groups coded 13 to 15, at the same time, Bouvet and Jeanjean (Bouvet 
1989) described five DNA groups of proteolytic Acinetohacter isolates, numbered 
13 to 18. The group 13 described by Bouvet and Jeanjean appears to correspond 
to the group 14 described by Tjemberg and Ursing, while for the other groups no 
correlation is apparent. Thus, different DNA groups have the same numbers, 
which may add to the confosion regarding the present subdivision of the genus. 
As a result, in the many studies reporting the clinical significance of 
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Acinetobacter species or the isolation of Acinetobacter strains from hospital 
outbreaks, the identity of Acinetobacter species described remains unclear (Allen 
1987, Gemer-Smidt 1987, Siau 1996). 
A. baumannii has been reported to be the most common species found in clinical 
specimens in European studies (Bouvet 1987, Seifert 1993, Genneri 1993). Unlike 
findings by others, genomic DNA group 3 was found in this study as important as 
A. baumannii in clinical specimens in Hong Kong (Section 3.2.1). One of the 
possible reasons may be that the isolates had been previously incorrectly 
identified or classified under the old taxonomy scheme. Seifert et al. (1993) 
reported that 72.9% of 582 isolates from 420 patients in 12 different hospitals 
over a 12-month period were A. baumannii. The identification of the 
acinetobacters was mainly based on the phenotypic identification scheme of 
Bouvet and Grimont (1987), and the tests included growth in tryptic soy broth 
(TSB) at 37, 41 and 44®C, gelatin hydrolysis, acid production from glucose in OF 
medium and utilization of 14 carbon sources. However, a recent study has shown 
that phenotypic identification can be problematic (Dijkshoom 1990), and this was 
especially for the members of the Acb complex (Bouvet 1987, Gemer-Smidt 
1991). Our results are also different from the previous findings in Hong Kong 
(Siau 1996, Ling 1996). In Siau's study, they reported that most (80%) isolates of 
Acinetobacter in clinical specimens belonged to A. haumannii or genomic DNA 
group 13TU. They identified the isolates by routine biochemical tests and growth 
at 44°C. Identification of A. baumannii or genomic DNA group 13TU based on 
the growth at 44°C has been found to be unreliable, as not all A. baumannii or 
genomic DNA group 13TU grow at this temperature. (Gemer-Smidt 1991, Traub 
1996). In another study from Ling et al (1986)，77% of the 140 Acinetobacter 
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isolates from the blood cultures was A. baumannii. The species identification of 
the isolates was based on the API 20NE in conjunction with the growth 
temperature at 37�C, 41�C and 44�C. The current database of the API 20NE 
(version 6.0) includes only seven named species of the 19 genomic DNA groups, 
it is not surprising that genomic DNA group 3 has not been identified by API 
20NE. A recent study by Bernards et al. (1996) showed that the discriminative 
power of the tests in the API 20NE was insufficient for correct identification of all 
Acinetohacter genomic groups, with the exception of A. baumannii Of the 12 
strains of genomic DNA groups 3, 11 were incorrectly identified as A. baumannii 
and one as A. junii. Thus, the same API profiles can be shared by different 
genomic DNA groups. 
In summary, the confusing state of Acinetohacter taxonomy has prevented 
ecological and epidemiological studies of these bacteria. The application of the 
new taxonomic schemes in the study of the genus would improve our knowledge 
of their specific habitats and clinical relevance of different genomic DNA groups. 
The identification of Acinetohacter isolates in this project was based on the use of 
the modem molecular technique, ARDRA, and a nomenclature scheme which has 
been successfully applied in other studies (Bernards 1997, Koeleman 1998). 
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7.2 Epidemiology and clinical implication of Acinetobacter species in 
Hong Kong 
It is now recognized that Acinetobacter plays a significant role in colonization and 
infection of patients admitted to the hospital, especially for patients in the 
intensive care unit (ICU). Acinetobacter has been isolated from various types of 
opportunistic infections, including septicaemia, pneumonia, endocarditis, 
meningitis, wound and urinary tract infections (French 1980, Ng 1989, Joly-
Guillou 1992). Their predominant role is in nosocomial respiratory infections, 
particularly ventilator-associated pneumonia. These bacteria are also responsible 
for difficult-to-treat infections because of the multiple resistance to the major 
antibiotics available for the treatment of nosocomial infections. Various risk 
factors predisposing patients to Acinetobacter infections have been identified. 
Susceptible patients include those with severe underlying diseases, e.g. 
malignancy, burns, invasive procedure surgery or immunosuppression. Various 
therapies which may contribute to the impairment of a patient's resistance, e.g., 
corticosteroids, anti-cancer chemotherapy, assisted ventilation, are also considered 
to be risk factors. The use of broad spectrum antibiotics plays a major role in 
selecting strains of Acinetobacter with an extended patterns of antibiotic 
resistance. These factors explain why Acinetobacter is responsible for many 
nosocomial infections in ICUs. Community-acquired acinetobacter infections are 
relatively rare. Community-acquired pneumonia (Goodhart 1977, Rudin 1979) 
and urinary tract infection (Hofiman 1982) by acinetobacters have been reported. 
Acinetobacter is an important nosocomial pathogen in our region, Hong Kong, 
with a prevalence of infection higher than previous data in Hong Kong (Ng 1986， 
Ling 1986, Siau 1986). There are many studies in the literature showing that A. 
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baumannii is the predominant species involved in infection (Bergogne 1996, Dy 
1999, Gomez 1999, Siau 1996). As discussed above, many of these studies, 
however, were based on outbreak strains or did not use reliable methods for 
genomic DNA groups identification. In this project, we studied isolates from 
clinical specimens, carriage sites and environmental samples with modem 
techniques. A total of 52 Acinetobacter isolates from surveillance screening, 134 
from the routine laboratory, 235 from carriage sites, 45 from vegetables and 34 
from soil samples were identified by ARDRA. For clinical specimens, we did not 
study the clinical significance of positive samples. Others have shown infection 
rates of 30-55% among patients with positive specimens (Dy 1999, Villari 1999). 
Ng et al (1996) reported that 72% of Acinetobacter blood cultures were of 
clinical significance. In this project, the prevalence of Acinetobacter species by 
surveillance screening of clinical specimens was found to be 2.4%, with the lower 
respiratory tract accounting for 11% of all isolates. Only some of the screening 
positive isolates were reported by the routine laboratory, thus the laboratory 
reported rate was significantly lower than the surveillance screening (Chi Square 
test, P < 0.001). Isolates of GDG 16, 17 and 8 of 13 AUA recovered in the 
screening were not reported. Similarly, 16 of 51 isolates in the Acb complex were 
not reported. This could mean that they were not regarded as significant isolates at 
the time of examination by the routine laboratory. Given that acinetobacters were 
isolated readily from carriage sites of both the healthy and the sick, and from 
environment, contamination of clinical specimens from carriage sites and the 
environment could readily occur. This raises the problem of distinguishing 
clinically significant isolates from those not clinically significant. It was originally 
planned to identify all the isolates from the surveillance screening for the study of 
100 
distribution of different genomic DNA groups in clinical sites. Unfortunately, 
20% of the isolates from the summer collection and 17% from the winter 
collection did not survive well on NA slopes. Such a high loss is expected to 
affect the results. Because the loss of the winter collection was smaller than that of 
the summer and only one of the 11 winter acinetobacters which failed to grow 
from subculture was reported by the routine laboratory, we selected the isolates 
from the winter collection for the distribution study. 
The reported isolates from the surveillance screening — Jan 1997) and the 
routine isolation collection (27伪 Oct - Sept 98) were combined for the analysis 
of the distribution of genomic DNA groups in clinical specimens. We found that 
A. baumannii (31%) and genomic DNA groups 3 (29%) were the common species 
in clinical specimens. A. baumannii and genomic DNA group 3 appeared to be 
able to infect, colonize or contaminate different sites readily. As a guide to the 
relative clinical significance of different genomic DNA groups, we studied blood 
culture isolates, although it is recognized that some isolates may be the result of 
contamination (Ng 1996). We found that genomic DNA group 3 was the 
commonest (40%) in blood cultures. This finding was different from the European 
and North American studies (Bergogne 1996, Gennari 1993, Horrevorts 1995). 
They found that A. baumannii and genomic DNA group 13TU were the common 
species in clinical specimens, and genomic DNA group 3 was uncommon 
(Bergogne 1996, Gennari 1993). In this project, genomic DNA group 3 was also 
the commonest species on superficial carriage sites among chronic patients and 
healthy volunteers, while A. baumannii was the commonest among acute patients. 
Berlau et al. (1999) reported that the most common genomic DNA group isolated 
from skin and mucous membranes of patients and controls in London was A. 
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Iwoffii, followed by genomic DNA group 15BJ, with A. baumannii and genomic 
DNA group 3, accounting for less than 5%. Genomic DNA groups 7 and 5 were 
reported in the German carriage study (Seifert 1997) but not found at all in the 
London study. Thus, there appear to be geographical differences in the distribution 
of genomic DNA groups. 
Acinetobacters have been shown to resist desiccation (Houang 1998, Jawad 1998) 
and survive well on fingertips and inanimate objects (Musa 1990). Based on the 
experiences with other nosocomial pathogens, we suggest that skin colonization 
of patients may play a role in the contamination of the hands of hospital staff 
through direct or indirect contact with the environment and fomites (Musa 1990). 
Unlike other Gram-negative organisms, airborne transmission of Acinetobacter is 
also possible, as described by Allen and Green in an outbreak of infection 
associated with contaminated fomites, e.g. bed linen and curtains (Allen 1987). 
Then, Craven et al, (1984) demonstrated that ventilator-associated medication 
nebulisers, when seeded with acinetobacters, produced aerosols containing a high 
number of Acinetobacter. Dry vectors can be secondary reservoirs during 
outbreak and during sporadic cases (Gerner-Smidt 1987, Allen 1987, Craven 
1984). 
A recent study in London reported 17% of vegetables bought from local 
supermarkets yielded Acinetobacter, with A. baumannii and genomic DNA group 
11 being the most common, each with a frequency of 27% (Berlau 1999). It is 
therefore suggested that vegetables may be a habitat of A. baumannii and provide 
a route by which these bacteria are introduced into the hospital. We showed here 
that genomic DNA group 3 and A. baumannii can be readily recovered from 
locally grown vegetables and soil samples, with a frequency of 26% and 8% 
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respectively. Raw food may be contaminated from a variety of sources and serve 
as vehicles of transmission. We cannot exclude the possibility that some of the 
vegetable isolates could have resulted from contamination by handlers, although 
we used only the inside leaves for sampling. It is curious that soil samples taken 
during the winter from the same location as sampled in the summer did not yield 
any isolates of genomic DNA group 3. Since no isolates of genomic DNA group 
13TU was found in environmental samples, they appeared to have a habitat 
restricted to clinical environments and carriage sites. Whereas the habitat of 
calcoaceticus (genomic DNA group 1) seems to be confined to environmental 
sources as no isolates of this species were found in clinical specimens. 
Infected or colonized patients seem to be one of the reservoirs of A. baumannii or 
genomic DNA group 3 in hospitals. In outbreaks of Acinetohacter infections, 
contaminated equipment or carriage by hospital staff are frequent sources of 
infection (Getchell-White 1989, Go 1994). It is not certain whether there is a 
critical level of contamination before the environment can be regarded as a 
significant reservoir for endemic infections. Given the ready occurrence of 
acinetobacters in carriage sites, vegetable and soil in our region, it is unrealistic to 
aim for the eradication of the organism from the environment in hospitals. Means 
to interrupt the transmission among staff and patients are most important, for 
example, staff hand washing and barrier precautions for contact isolation. 
In summary, our findings indicate that genomic DNA groups of the Acb complex 
commonly isolated from clinical specimens can readily be found on the carriage 
sites of both patients and healthy volunteers, and in the environments both inside 
and outside the hospital. Unlike findings in other parts of the world, genomic 
DNA group 3 was commonly carried by the local population in Hong Kong. It is 
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readily present in the environment and also plays a significant role in clinical 
infections. 
7.3 Characterization of Acinetohacter 
Our results showed that of all genomic DNA groups examined, A. baumannii was 
the most resistant. High resistance rates of Acinetohacter species to 3��generation 
cephalosporins (35% to ceftazidime), and fluroquinolones (27% to ciprofloxacin 
and 13.5% to levofloxacin) were demonstrated. Aminoglycosides, sulbactam and 
imipenem were active, especially against Acinetohacter genomic DNA groups 
other than A. baumannii. In addition, there were significant differences in 
antimicrobial susceptibilities of the same genomic group obtained from different 
sources, e.g. between clinical and non-clinical isolates of genomic DNA group 3, 
and of different genomic groups obtained from the same source. This highlights 
the importance of delineation of genomic groups Acinetohacter when comparing 
susceptibility data from different studies. 
Selected isolates were used to assess the usefulness of tDNA fingerprinting for 
delineation of Acinetohacter genomic DNA groups. However, our results showed 
that it had low discrimination for the 19 genomic DNA groups. It could be a 
choice in the screening for members of the Acb complex when a large number of 
isolates is involved such as in an outbreak situation. 
7.4 Future Work 
Very little is known about the clinical significance of Acinetohacter species other 
than “Acb complex", and further detailed investigations are required. There have 
been few studies of Acinetohacter isolates from environmental sources. Improving 
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our knowledge of their natural habitats would be important in understanding their 
clinical significance. 
ARDRA performed well in this project in the discrimination of genomic DNA 
groups, including those in Acb complex. The present ARDRA classification, 
however, is largely based on clinical strains from Europe. This may explain why 
20% of our isolates were not classifiable by the ARDRA scheme, especially for 
those from environmental sources (42%). These isolates may represent new 
patterns of existing genomic DNA groups or new genomic DNA groups. 
Expansion of the ARDRA database is therefore required for isolates from 
different sources and different geographical regions. 
• • . 
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APPENDIX 1 
Pictures of ARDRA patterns obtained after restriction of the amplified 16S rRNA 
gene with five restriction enzymes from Dijkshoom et al. (1998) 
C f o 丨 AM Mbol R s a 丨 Mspl 
M M M M M M 
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M, molecular size marker (100-bp ladder). Numbers below each lane correspond to ARDRA 





















































































































































ARDRA profiles of 202 Acinetobacter reference strains previously identified to 
genomic DNA groups by the use of DNA-DNA hybridization (Dijkshooml998). 
Strain'' Designation as received Source Restriction Patterns 
and/or other designations*^ 
Cfol Alu\ Mbol Rsal Mspl 
Genomic species 1 {A. calcoaceticus) 
RUH 2 2 0 r ATCC 23055口，r soil 2 2 1 1 3 
RUH 54 LMD 22.17, T soil 2 2 1 1 3 
RUH 583 3' soil 3 2 1 1 3 
RUH 584 soil 2 2 1 1 3 
RUH 944 5" i.v.catheter 2 2 1 1 3 
RUH 582 soil 2 2 1 1 3 
RUH 2202 42^ 7 � wound 2 2 1 1 3 
RUH 2203 132^8' wound 2 2 1 1 3 
Genomic species 2 {A. baumannii) 
RUH 2207 91^9' sputum 1 1 1 2 3 
RUH 112 10' wound 1 1 1 2 3 
RUH 88 i r wound 1 1 1 2 3 
RUH 1147 \ r toe web 1 1 1 2 3 
RUH 510 13" bronchus 1 1 1 2 1 
RUH 1052 LMD 82.54, 14" not known 1 1 1 2 1+3 
RUH 1063 NCTC 7844, 15" not known 1 1 1 2 1 
RUH 557 urine 1 1 1 2 3 
RUH 48 17' wound 1 1 1 2 3 
RUH 413 19" pus 1 1 1 2 1 
RUH 336 20' sputum 1 1 1 2 3 
RUH 2208 1 4 < 2 r wound 1 1 1 2 3 
RUH 871 22" urine 1 1 1 2 1 
RUH 230 23"= wound 1 1 1 2 3 
RUH 872 24® urine 1 1 1 2 1 
RUH 2209 ATCC 17904d,25e urine 1 1 1 2 3 
RUH 1019 26' wound 1 1 1 2 1 
RUH 213 I T sputum 1 1 1 2 1 
RUH 882 28e urine 1 1 1 2 1 
RUH 436 29' sputum 1 1 1 2 1 
RUH 523 30" urine 1 1 1 2 3 
RUH 134 3 r urine 1 1 1 2 3 
RUH 215 32® blood 1 1 1 2 1 
RUH 875 33' urine 1 1 1 2 1 
RUH 150 34' urine 1 1 1 2 3 
RUH 3023^ CCUG 19096^^ urine 1 1 1 2 1 
ATCC 19606丁, 35® 
RUH 1093 36' sputum 1 1 1 2 1 
RUH 332 r r blood 1 1 1 2 3 
RUH 210 38' sputum 1 1 1 2 3 
RUH 128 39' sputum 1 1 1 2 3 
RUH 97 40® sputum 1 1 1 2 3 
RUH 447 4 r catheter tip 1 1 1 2 1 
RUH 414 42' ear 1 1 1 2 1 
RUH 3242 if burn 1 1 1 2 1 
RUH 3344 2f bum 1 1 1 2 1 
RUH 2032 sputum 1 1 1 2 1 
RUH 2033 f sputum 1 1 1 2 1 
RUH 3370 16� resp 1 1 1 2 3 
120 
Genomic species 2 (A. baumannii) (continued) Cfol Alu\ Mbol Rsal Mspl Bfal BsmAl 
RUH3371 17� resp 1 1 1 2 3 
RUH 1752 13® bronchus 1 1 1 2 1 
RUH2180 19« sputum 1 1 1 2 3 
RUH 3238 GNU 1084,7g bum wound 1 1 1 2 1 
RUH 3429 TU 147,24^ wound 1 1 1 2 1 
RUH 1486 17® umbilicus 1 1 1 2 1 
RUH 1907 bronchus 1 1 1 2 3 
RUH 2688 22® pharynx 1 丨 1 2 1+3 
RUH 3239 GNU 1 0 8 3 , u r i n e 1 1 1 2 1 
RUH 3240 GNU 1 0 8 6 , r e s p . t r a c t 1 1 1 2 3 
RUH 3242 GNU 1082,5® wound 1 1 1 2 1 
RUH 3245 GNU 1080,3® CSU 1 1 1 2 3 
RUH 3247 GNU 1078, rectal mucosa 1 1 1 2 1 
RUM 3281 GNU 1081,4« trach.aspirale 1 丨 1 2 1 
RUH 3282 GNU 1079,2® trach. site 1 1 1 2 1+3 
RUH 3410 MB 142,29® skin 1 1 1 2 1 
RUH 3413 SJH9/MB 264,30® skin 1 1 1 2 1 
RUH 3423 PGS 9971,26® urine 1 1 1 2 1 
RUH 3425 PGS 10086,28» urine 1 1 1 2 3 
RUH 3414 SJH26/MB 228, 3 n a i l fold 1 1 1 2 1 
RUH 3422 PGS 189, 25® crural ulcer 1 1 1 2 3 
RUH 3424 PGS 1 0 0 7 4 , u r i n e 1 1 1 2 1 
RUH 3428 TU 133,23® wound 1 1 1 2 3 
RUH 3212 04/90 Vlf vlflow 1 1 1 2 1 
RUH 3323 patRh blood 1 1 1 2 1+3 
Genomic species 3 
RUH 2204 102^ 43' wound 2 1 3 1 3 
RUH 502 44® drain 2 1 3 1 3 
RUH 1163 45® toe web 2+3 1 3 1 3 
RUH 2205 162^ 46' wound 2 1 3 1 3 
RUH 1020 AT bronchus 2 1 3 1 3 
RUH 411 48" sputum 2 1 3 1 3 
RUH 509 49® bronchus 2 1 3 1 3 
RUH 37 50' blood 2 1 3 1 3 
RUH 408 5V not known 2+3 1 3 1 3 
RUH 468 52" urine 2 1 3 1 3 
RUH 56 LMD 79.41,53" not known 2 1 3 1 3 
RUH 532 54" urine 2 1 3 1 3 
RUH 2206 ATCC 19004d,55e CSF 2 1 3 1 3 
RUH 1942 llf urine 2 1 3 1 3 
RUH 1944 urine 2 1 3 1 3 
RUH 1026 58' urine 2 1 3 1 3 
RUH 1266 19' bronchus 2 1 3 1 3 
RUH 1444 1' urine 2 1 3 1 3 
RUH 3330 patMh blood 2 1 3 1 3 
RUH 3353 patT^ blood 2 1 3 1 3 
RUH 2783 pat iii'' liquor 2 1 3 1 3 
RUH 3199 patDh tube 2 1 3 1 3 
RUH 3201 08/89 IVh sink 2 1 3 1 3 
RUH 3202 08/89 IVh sink 2 1 3 1 3 
RUH 3321 pat Ah blood 2 1 3 1 3 
RUH 3334 patRh blood 2 1 3 1 3 
121 
Genomic species 4 (A. haemolyticus) Cfol Alul Mbol Rsal Mspl Bfal 
RUH 2213 197^ 56" wound 1 4 1 2 2 1, 
RUH415 5T pus 1 4 1 2 2 1 
RUH 55 LMD 70.9,58' not known 1 4 1 2 2 1 
RUH 406 Gilardi 2890,59' not known 1 4 1 2 2 1 
RUH 2215^ ATCC 17906^^ 60" sputum 1 4 1 2 2 1 
RUH 44 6 r air 1 4 1 2 2 1 
RUH 2214 61^ 62" not known 1 4 1 2 2 1 
Genomic species 5 (A. junii) 
RUH 2228^ ATCC 17908^'', 63' urine 1 2 1 2 3 3 
RUH 204 64® blood 1 2 1 2 3 3 
RUH 383 65' not known 1 2 1 2 3 3 
RUH 2229 124^ 66' surgical gown 1 2 1 2 3 3 
RUH 2230 178^ 6T water 1 2 1 2 3 3 
RUH 3198 patch sputum 1 2 1 2 3 3 
Genomic species 6 
RUH 2867 ATCC 17979^ 68' throat 1 1 2 2 2 
LUH 286 MGH 97923,39^ urine 1 1 2 2 2 
Genomic species 7 (A. johnsonii) 
RUH 223 r ATCC 17909^ ^ 69' gut 1 4 1 2 2 2 
RUH 2233 92\ l(f urine 1 4 1 2 2 2 
RUH 2855 68^ 7 r urine 1 4 1 2 2 2 
RUH 2856 9l\ IT urine 1 4 1 2 2 2 
RUH 2857 112^ I T urine 1 4 1 2 2 2 
RUH 2232 153^ 75" faeces 1 4 1 2 2 2 
RUH 2859 137^ 76' urine 1 4 1 2 2+3 2 
LUH 540 LMD 90.19,21 OA* activated sludge 1 4 1 2 2 2 
RUH 2858 134^ 74' urine 1 4 1 2 2 2 
Genomic species 8 / 9 Iwoffii) 
RUH 2219^ NCTC 5866f’d，77' not known 3 3 2 1 2 
RUH 551 78® not known 3 3 2 1 2 
RUH 45 79' blood 3 3 2 1 2 
RUH 2221 44'', 80' prostate seer. 3 3 2 1 2 
RUH 548 8ie eye 3 3 2 1 2 
RUH 74 82® not known 3 3 2 1 2 
RUH 302 83� skin 3 3 2 1 2 
RUH 1104 84® skin 3 3 2 1 2 
RUH 1115 85" skin 3 3 2 1 2 
RUH 549 86" urine 3 3 2 1 2 
RUH 303 87' door 3 3 2 1 2 
RUH 709 88" wound 3 3 2 1 2 
RUH 2220 202^ 89" urine 3 3 2 1 2 
LUH 1710 62^CIP 70.31, gangreri.lesion 3 3 2 1 2 
ATCC 995t 
LUH 1711 63"\ SEIP Ac 84.203 chicken 3 3 2 1 2 
LUH 1712 6 r , SEIP 14.84 sperm culture 3 3 2 1 2 
LUH 1713 65^ CIP A162, conjunctivitis 3 3 2 1 2 
ATCC 17968'' 
LUH 1714 66^ CIP 70.19, not known 3 3 2 1 2 
ATCC 17984 
LUH 1715 67m, SEIP 4.83 pus 3 3 2 1 2 
Genomic species 10 
RUH 2222 198^ 90" urine 4 2 1 2 3 1 
RUH 2223 113:2d，9ie wound 4 2 1 2 3 1 
RUH 2224 ATCC 17924^ 92' not known 4 2 丨 2 3 1 
122 
Genomic species 11 Cfol Alu\ Mbol Rsai Mspl Bfal BsmAl 
RUH 2234 174^ 93' contact lens 4 2 1 2 3 2 
RUH2861 CIP 63.46^ not known 4 2 1 2 3 2 
ATCC 11171,94" 
RUH 1050 LMD81.109,95' not known 4 2 1 2 3 2 
RUH 2236 51^ 96' urine 4 2 1 2 3 2 
RUH 2235 210^ 9T wound 4 2 1 2 3 2 
RUH 2860 58b^ 98' wound 4 2 1 2 3 2 
LUH 287 MGH 97931,225'' sputum 4 2 1 2 3 2 
Genomic species 12 (A. radioresistens) 
RUH 2225 109^ 99' urine 7 3 2 2 1 
RUH 2864 SEIP 12.8ld, lOOe urine 7 3 2 2 1 
RUH 2226 152^ 101' wound 7 3 2 2 1 
RUH 2862 26^ 102' sputum 7 3 2 2 1+3 
RUH 2865^ FO-lT’d,iAM13186T,l03e cotton 7 3 2 2 3 
RUH 2863 73^104" wound 7 3 2 2 3 
RUH 2227 50^105' urine 7 3 2 2 1+3 
RUH 3517 feather pillow 7 3 2 2 3 
Genomic species 13 sensu Bouvet & Jeanjean / Genomic species 14 sensu Tjernberg & Ursing 
LUH 1718 134", SEIP 5.84 blood 1 4 1 2 2 1+2 
LUH 1719 376", K. Irino 214/84 CSF 1 4 1 2 2+3 5 
LUH 1720 496", SEIP 86.66 skin 1 4 1 2 2 1 
LUH 1721 552", SEIP Ac 86.158 skin 1 4 1 2 2+3 5 
LUH 1722 943",SEIPAc87.315 unknown 1 4 1 2 2+3 5 
human origin 
LUH 1723 1001", SEIP Ac 87.348 skin 1 4 1 2 2+3 5 
LUH 1724 1158", SEIP Ac 88.239 skin 1 4 1 2 2 1 
LUH 1725 1191", P.Osterrieth 190 catheter 1 4 1 2 2+3 5 
RUH 2216 7ld, i n e conjunctiva 1 4 1 2 3 1 
RUH 2866 118" CSF 1 4 1 2 3 1 
RUH 2217 10ld，119e conjunctiva 1 4 1 2 3 1 
RUH 2218 ATCC 17905�120= conjunctiva 1 4 1 2 2+3 6 
RUH 3206 pa t l f sputum 1 4 1 2 3 1 
RUH 3207 pat f sputum 1 4 1 2 3 1 
RUH 3211 04/90 Vf resp.flow meter 1 4 1 2 3 1 
Genomic species 13 sensu Tjernberg & Ursing 
RUH 2210 ATCC 17903^ 106' not known 2 1 丨 1 1 
RUH 2624 丨 07e skin forehead 2 1 1 1 1 + 3 
RUH 2285 108' bronchus 2 1 1 1 3 
RUH 2376 109' sputum 2 1 1 1 3 
RUH 503 110® urine 2 1 1 1 3 
RUH 2041 11” post mortem 2 1 1 1 1+3 
RUH 2284 112' bronchus 2 1 1 1 3 
RUH 2627 113e rectum 2 丨 1 1 3 
RUH 412 114' blood 2 1 1 1 1 
RUH 2211 100^ 115' gastric fistula 2 1 1 1 3 
RUH 2212 165 ^ 116' urine 2 1 1 1 3 
RUH 3417 2lf sputum 2 1 1 1 3 
RUH 3418 22f sputum 2 1 1 1 3 
123 
Genomic species 14 je/wi^ Bouvet &Jeanjean Cfo\ AM Mbol Rsal Mspl Bfal BsmAl 
LUH 1087 MGH 9968l,K.lrinol05/85 conjunctiva 5 5 1 2 3 
LUH 1088 MGH 99871，CCUG 14816 wound 5 5 1 2 3 
LUH 1726 382", K. Irino 105/85 conjunctiva 5 5 1 2 3 
LUH 1727 513", CCUG14816, wound 5 5 1 2 3 
Gilardi GLG4638 
LUH 1728 743", not known 5 5 1 2 3 
RE Weaver CDC E655 
Genomic species 15 sensu Bouvet & Jeanjean 
LUH 1729 79", skin 1 2 1 2 2 2 
M.M.Adam Ac606 180:40 va. 
LUH 1730 81", SEIP 23.78 urine 1 2 1 2 2 
Genomic species 15 sensu Tjernberg & Ursing 
LUH 1090 15 丨 ad, MGH 98795 urine 6 2 1 1 3 
LUH 1091 118d,MGH98794 faeces 6 2 1 1 3 
Genomic species 16 
LUH 1731 78", CIP 70.18, urine 1 2 1 4 2 
ATCC 17988 
LUH 1732 673",SEEP Ac87.123 urine 1 2 1 4 2 
LUH 1733 l O i r skin 1 2 1 4 2 
LUH 1734 12ir,P.Osterrieth312 faeces 1 2 1 2+4 2 
Genomic species 17 
LUH 1735 641", SEIP 2/87 wound 1 2 1 2 3 4 
LUH 1736 942",SEEP Ac87.314 leg ulceration 1 2 1 2 3 4 
Unclassified strains 
LUH 1738 631", CCUG 14818 ear 1 2 1 2 2 
LUH 1739 640", SEIP 1/87 wound 1 2 1 2 3 
LUH 1737 80", SEEP 14.83 blood 1 4 1 4 3 
LUH 1740 930", SEIP 87.302 trach. exudate 1 4 1 4 3 
LUH 1741 944", SEIP Ac87.316 wound 1 4 1 4 3 
LUH 1742 1240", RUH 65 clinical spec 1 4 1 4 3 
LUH 1743 1271", RUH 422 urine 1 5 1 2 3 
LUH 1469 MGH 99613, 10095° abscess 3 5 1 1 3 
LUH 1470 MGH 99614, 10169° sputum 3 5 1 1 3 
LUH 1471 MGH 99896,5804" blood 3 1 3 丨 3 
LUH 1472 MGH 99685, 10090° ulcer 3 1 1+3 1 3 
RUH 3329 patKh blood 1 4 3 4 3 
RUH 53 ATCC 13809 soil 2 5 1 1 3 
RUH 175 blood 1 2 1 4 3 
RUH 203 liquor 1 2 1 2 2 
RUH 581 soil 3 3 1 1 2 
RUH 1139 throat 3 1 1 1 3 
‘ T, type strain 
b Designations of collection L. Dijkshoom, RUH=Rotterdam University Hospital, LUH=Leiden University Hospital 
ATCC, American Type Culture Collection, Rockville, Md, USA; LMD, LMD Culture Collection, University of 
Technology, Delft, The Netherlands, NCTC, National Collection of Type Cultures, London, United Kingdom; 
CCUG, Culture Collection, University of GOteborg, GOteborg, Sweden; CIP, Collection de I'lnstitut Pasteur, Paris, 
France; SEIP, Service des Ent^robact dries de I'lnstitut Pasteur, Paris, France; I AM, Institute of Applied Microbiology, 
The University of Tokyo, Tokyo, Japan, MGH, Collection of Malmoe General Hospital, Malmoe, Sweden, 
d Designation used by Tjernberg & Ursing, APMIS 1989’ 595-605 
c Serial no. used by Dijkshoorn et al.. System. Appl. Microbiol. 1990, 338-344 
f Designation used by Dijkshoom et al., J Clin. Microbiol. 1993，702-705. 
s Designation used by Dijkshoom et al., J Clin. Microbiol. 1996, 1519-1525 
h Designation used by Horrevorts et al., J Clin. Microbiol. 1995, 1567-1572 
‘ Designation used by Dijkshoom et al.，J Clin. Path. 1993，46:533 
k Designation used by Gemer-Smidt et al., J Clin. Microbiol. 1991, 277-282 
‘ Designation used by Bonting et al., FEMS Microbiol. Ecol. 1992, 57-64 
" D e s i g n a t i o n used by Bouvet & Grimont, Int. J. System. Bacteriol. 1986，228-240 
“ Designation used by Bouvet & Jeanjean, Res. Microbiol. 1989, 291-299 
" S t r a i n no. used by Gemer-Smidt & Tjernberg，APMIS 1993，826-832 
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APPENDIX 1 
Detail descriptions of the ARDRA profiles of the ARDRA unclassifiable 
acinetobacters (AUA) found in this project. 
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